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Abstract 
Wastewater management in the Canadian Arctic is challenging due to the extreme climate 
and lack of conventional treatment system infrastructure. To resolve these issues, most 
Northern communities use waste stabilization ponds (WSPs) as their sole form of wastewater 
management. In this type of system, wastewater is collected directly from buildings year-
round and is transported to the WSP where it is discharged directly into the environment. For 
approximately nine months of the year, the wastewater remains frozen due to sub-zero 
temperatures. As the temperature increases in the spring, ice begins to melt, allowing the 
wastewater to thaw and flow into downstream lakes. Increased sunlight and increased water 
temperatures stimulate microorganisms to naturally breakdown the various components of 
the wastewater and reduce concentrations of macronutrients, such as nitrogen and 
phosphorus. The two to three months during which temperatures remain above zero are 
collectively referred to as the treatment season as the majority of aerobic and anaerobic 
degradation occurs during this time.  
Currently, the microbial communities of Arctic WSPs are not well understood. 
Identifying the major microorganisms in the microbial communities of these WSPs is 
important for understanding whether the wastewater treatment system is effective in the 
removal of wastewater contaminants from effluent water flowing into downstream lakes. 
This research aims to characterize the microbial community and identify wastewater 
indicator organisms of three Arctic WSPs in Baker Lake, Cambridge Bay, and Kugluktuk in 
Nunavut, Canada, with a focus on the Baker Lake WSP and the downstream lake system. In 
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Baker Lake, wastewater is discharged into a lagoon, where water is able to flow into 
downstream lakes before ultimately discharging into Baker Lake. Several sites across this 
entire system, as well as three reference sites were sampled and analyzed to produce baseline 
taxonomic profiles. This was achieved through 16S rRNA gene and metagenome sequencing, 
and subsequent taxonomic assignment to 16S rRNA gene amplicons, metagenome sequences 
corresponding to the rpoB gene, and metagenome-assembled genomes (MAGs).  
Both temporal and spatial variation were observed across Baker Lake sampling sites, 
with clear differences in microbial community composition at samplings sites at the phylum, 
family, and ASV levels. These trends were observed in each of the 16S rRNA gene, rpoB 
gene, and MAG taxonomic assignments. Wastewater indicator species were identified for the 
Baker Lake WSP and these indicator microorganisms were not detected in most downstream 
sites. The three WSPs were also found to have very different microbial communities, with 
few overlapping ASVs. Despite these differences at the ASV level, the three WSPs contained 
common groups of microorganisms and microbial community profiles were distinct from 
Arctic freshwater lake samples. Most of the ASVs detected in all three WSPs belonged to the 
phylum Proteobacteria, which had a relative abundance of >50% in nearly all WSP samples. 
The proportion of Proteobacteria was much lower in lakes found downstream of the Baker 
Lake WSP. In receiving waters and reference lakes, Bacteroidetes, Actinobacteria, 
Planctomycetes, and Verrucomicrobia were more prevalent. 
Wastewater is known to be a hotspot for antibiotic resistance gene (ARG) 
dissemination and evolution. This thesis also aimed to identify and quantify ARGs within the 
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WSPs, receiving waters, and reference lakes to determine if ARGs were enriched in samples 
containing wastewater. Eight gene families related to macrolide resistance, and one gene 
related to class A betalactamases were detected at higher abundance in wastewater samples 
than in downstream and reference lakes. Metagenome sequences related to these ARGs were 
also found to be in bins associated with five MAGs. 
This research is an important step in the characterization of microbial communities of 
wastewater in Arctic WSPs. The taxonomic profiles of the WSPs from Baker Lake, 
Cambridge Bay, and Kugluktuk provide important baseline data that will assist with 
monitoring of the wastewater system and gives insights into the efficacy of WSPs as the sole 
wastewater treatment system for communities in the Arctic. This research will aid in tracking 
changes in microbial communities as operational and infrastructure upgrades are made to the 
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Chapter 1 
Introduction 
1.1 Municipal Wastewater Effluent and Eutrophication 
More than 80% of Canadians benefit from wastewater treatment system facilities1. Effluent 
from these facilities can deteriorate water quality of receiving waters2. Municipal wastewater 
effluent (MWWE) composition varies depending on region, but in general, MWWE contains 
solids, dissolved and particulate matter, nutrients, pathogenic and non-pathogenic bacteria, 
organic chemicals, metals, oils, and plastics1. Wastewater treatment plants (WWTPs) aim to 
reduce as many of these components as possible, focusing on reducing total suspended solids 
(TSS), chemical and biochemical oxygen demand (COD and BOD, respectively), nitrogen 
and phosphorus, pathogenic bacteria, and plastics1. Chemical oxygen demand is a measure of 
the amount of oxygen required to chemically oxidize organic matter, whereas BOD is the 
amount of dissolved oxygen required by microorganisms to oxidize organic matter3.  
When treated improperly, municipal wastewater effluent is a major cause of 
eutrophication, or nutrient enrichment, of many lakes, ponds, and rivers4. MWWE can 
contain increased concentrations of nitrogen and phosphorus, as well as other micronutrients, 
that are discharged into receiving waters4,5. The amount of nutrients present plays an 
important role in shaping the biological community composition, and nutrient enrichment can 
cause both direct and indirect biological changes, such as stimulation of algal growth or 
changes in fish communities caused by reduced oxygen4. Often, the growth of organisms is 
limited by the amount of nutrients present. In conditions where nutrients are the limiting 
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factor, eutrophication can stimulate the growth of algal species. This may include species that 
produce toxins, such as the diatom Pseudo-nitzschia, that are released into the water, as well 
as those that produce large amounts of biomass, such as the green macroalga Cladophora, 
which can cause hypoxia of other aquatic organisms, including microorganisms4,6. Fish 
communities of receiving waters are typically impacted by algal blooms, with increased fish 
kills in these circumstances4. 
1.1.1 Impact of MWWE on Microbial Communities 
Many studies have documented impacts of wastewater effluent on receiving waters. For 
example, shifts in microbial communities can be detected at the phylum level when 
comparing wastewater effluent to downstream sites7, microbial counts increase at sites 
downstream of wastewater effluent discharge sites8, and microorganisms from the effluent 
itself are able to persist at these downstream sites9. In addition, microbial community 
diversity decreases in sediment of downstream sites10 and these impacted sediment sites are 
associated with decreased abundances of sulfate reducers, denitrifiers, and methanogens in 
comparison to sediments of upstream sites11. Microplastics from wastewater effluent 
positively influence the ability of microorganisms to form biofilms and increase the ability of 
these microorganisms to survive downstream12. Overall, microbial community composition 
is impacted by wastewater effluent discharge. 
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1.1.2 Role of Microorganisms in Reducing Wastewater Nutrient Contaminants 
Microorganisms play an important role in the reduction of nutrients from wastewater and 
reduce the potential for eutrophication. Specifically, the removal of nitrogen and phosphorus 
is an important role played by microorganisms in wastewater treatment13. 
Wastewater nitrogen exists primarily as organic nitrogen, ammonia, nitrite, and 
nitrate14. Unionized ammonia is an important contributor to wastewater effluent toxicity, 
both directly to fish, and also because nitrification decreases the amount of available oxygen 
for other organisms15,16. Because of this, WWTPs commonly employ biological nitrogen 
removal (BNR) processes in the form of activated sludge to reduce the amount of nitrogen 
being released into the environment17. During BNR, microorganisms in the activated sludge 
perform both nitrification and denitrification to help reduce inorganic nitrogen17. In the 
process of nitrification, ammonia-oxidizing bacteria (AOB) and ammonia-oxidizing archaea 
(AOA), use oxygen to convert ammonia to nitrite16,18. Nitrite is then oxidized by nitrite-
oxidizing bacteria, such as those in the genera Nitrobacter and Nitrospira, into nitrate16. Both 
nitrite and nitrate can be reduced to dinitrogen gas through the process of denitrification, 
which then dissipates16. The most common denitrifying bacteria are facultative anaerobes, 
which are able to reduce nitrate and nitrite in both oxic and anoxic conditions16,19.  
Phosphorus is a critical limiting macronutrient for algal growth, and phosphorus 
removal is also important for reducing eutrophication in receiving waters20. The most 
common form of phosphorus in wastewater is orthophosphate21. The biological process to 
remove phosphorus is referred to as enhanced biological phosphorus removal (EBPR)22. 
Phosphorus removal by EBPR is first done anaerobically, followed by aerobic stages of 
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treatment21. The anaerobic steps cause phosphates to be released from the activated sludge 
into solution, which is then aerated to stimulate phosphate uptake in higher concentrations 
than required by the microorganisms21. EBPR has been shown to remove more than 90% of 
soluble phosphorus21. Microorganisms involved in this process are primarily associated with 
Betaproteobacteria and Actinobacteria22. Chemical precipitation is also a commonly used 
process for the removal of phosphorus, where metal salts are applied to produce metal 
phosphates, which can then be removed from the water23,24.  
1.1.3 Wastewater and Antibiotic Resistance  
Antibiotic resistance has become a growing problem for society due to the frequent misuse of 
antibiotics. Although antibiotics originate from environmental bacteria, humans have 
provided strong selective pressures for antibiotic resistance genes (ARGs) since antibiotics 
were first used to treat and prevent infections25. As antibiotics became more prevalent in 
medical settings, selection of antibiotic resistant bacteria (ARB) and antibiotic resistance 
genes also increased26. These ARGs were thought to have first arisen within antibiotic-
producing bacteria, which would allow the microorganisms to protect themselves from the 
antibiotics25. Fecal bacteria also play a role in the selection of ARGs because they may have 
been exposed to high concentrations of antibiotics27.  
Because ARGs are commonly associated with plasmids that transfer between 
different bacteria through horizontal gene transfer (HGT), this has led to further 
dissemination of ARGs, and therefore ARB28. Microorganisms can transfer genes by HGT 
using three different methods: conjugation, transformation, and transduction29. During 
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conjugation, cells interact with one another via a conjugative pilus, which transfers genetic 
material from a donor to a recipient cell29,30. Transformation, in contrast, is limited to 
naturally competent bacterial cells incorporating free environmental DNA and is far less 
common mechanism 31. Transduction occurs when genetic material from a host bacterium is 
accidentally packaged alongside viral DNA into viral capsids, and transferred to a new 
recipient by infection via the bacteriophage transducing particle29. Within the context of 
wastewater treatment environments, conjugation is thought to be the primary mechanism for 
ARG transmission between bacteria through the use of conjugative plasmids32. 
Wastewater has been considered a hotspot for the dissemination and evolution of 
antibiotic resistance because most antibiotics used by humans appear in and are processed 
through municipal wastewater33. Here, bacteria from a variety of sources are exposed to 
sublethal concentrations of antibiotics and are able to develop antibiotic resistance. These 
ARB can pass their ARGs to non-resistant bacteria from different sources through HGT to 
produce new ARB34. This is especially a concern for human pathogens that may be present in 
wastewater, which also have the potential to acquire ARGs. 
With the regular identification of new ARGs, various databases have been created to 
gather information about ARG classes and further incorporate data about the associated 
proteins and literature. In particular, the Comprehensive Antibiotic Resistance Database 
(CARD) is manually curated to provide an updated database of all antibiotic resistance genes 
and associated metadata35. In the CARD, ARGs have been divided into commonly known 
classes such as aminoglycosides, b-lactams, chloramphenicol, macrolides, tetracyclines, and 
sulfonamides35. This database identifies ARGs from metagenome reads using a tool called 
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Short, Better Representative Extract Dataset (ShortBRED)36. The ShortBRED tool produces 
protein-family specific marker sequences by first clustering user proteins of interest into 
families using CD-HIT36–38. Multiple sequences alignments (MSA) are then made for each 
family using MUSCLE39 and Biopython40 to produce a consensus sequence for each family. 
These consensus sequences are then compared against one another as well as against a 
reference database using BLAST41, and sequences that are unique, or have minimal overlap 
from other protein families are identified. The identified marker sequences are then used to 
determine the relative abundance of the protein families in whole metagenome sequence data 
using USEARCH42. The raw number of hits is converted to a normalized count in reads per 
kilobase of reference sequence per million sample reads (RPKMs), which are output into a 
relative abundance table, which can be compared between different samples36. 
1.2 Waste Stabilization Ponds 
Waste stabilization ponds (WSPs) are the simplest forms of wastewater management43. Most 
wastewater treatment systems with WSPs require little or no equipment for treatment to 
occur43,44. These ponds are often engineered such that wastewater is stabilized through 
aerobic and anaerobic processes occurring naturally by microorganisms in the environment. 
Multiple WSPs can also be combined, each for the removal of different pollutants within the 
wastewater45. For example, facultative and anaerobic ponds are specifically designed for the 
removal of BOD, whereas aerobic ponds are better for removing pathogens45. Although 
WSPs remove contaminants efficiently, they are optimal for locations with a climate 
characterized by adequate sunlight exposure and high temperatures43. This is due to poor 
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biological activity in extremely cold conditions, such as those in Arctic environments, where 
there is limited sunlight and monthly average temperatures below zero for most of the year46. 
Sunlight is also a major factor governing the efficiency of WSPs in the removal of pathogens. 
Bacteria such as Escherichia coli, Campylobacter jejuni, and Salmonella enterica are 
sensitive to sunlight, which causes UV-associated DNA damage47. Bacteria are also able to 
repair UV damage in dark conditions, and therefore WSPs that have higher sunlight exposure 
are expected to be more efficient in the sustained removal of pathogens47. There are several 
types of WSPs, with the most common being facultative ponds, anaerobic ponds, aerated 
lagoons, maturation ponds, and high-rate algal ponds (HRAPs)47.  
1.2.1 Facultative Waste Stabilization Ponds 
The most common type of WSP is facultative WSPs (Figure 1.1). In Arctic settings, these 
WSPs are often used alone, with effluent discharged directly into the ocean, or with 
downstream water systems such that multiple stages of treatment can occur. Solid organic 
material settles to the bottom of the facultative WSP and forms a sludge. The bottom layer of 
the WSP is anoxic, allowing for anaerobic microorganisms to grow and digest the sludge. 
Organic carbon is ultimately converted to carbon dioxide and methane through combined 
anaerobic metabolic processes (e.g., fermentation and methanogenesis) and together, these 
help deplete organic material from wastewater. In the top layer of the pond, oxygen supports 
aerobic and facultative microorganisms through the mixing of water by wind and continued 
discharge of wastewater into the pond43. Oxygen also diffuses directly from the air and is 
produced by photosynthetic organisms, such as cyanobacteria and algae. With increased 
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sunlight during the treatment season, oxygen levels are highest during this time period, and 
therefore aerobic respiration decomposes much of the organic material in this layer45,46,48. In 
the most efficient systems, anaerobic and aerobic degradation are able to reduce up to 75% of 
the BOD45. Importantly, Arctic WSP systems are expected to be far less efficient in reducing 
BOD than temperate WSPs due to the influence of sub-zero temperatures on microbial 
activity46.  
 
Figure 1.1: Schematic diagram of a facultative waste stabilization pond. Figure adapted from 
Tilley et al.45 
 
1.2.2 Nutrient Removal in WSPs 
Given the importance of removing macronutrients from wastewater to prevent eutrophication 
in receiving waters, important design objectives for WSPs include the capacity for nitrogen 
and phosphorus removal. Nitrogen is removed in a similar fashion in WSPs as in 
conventional WWTPs, using a combination of nitrification and denitrification. However, 
additional physical and biological mechanisms may also be important for WSP treatment. 
The most important WSP mechanism for nitrogen removal is ammonia stripping43. This 
process works by converting ammonium into its unionized form. Higher concentrations of 
unionized ammonia are achieved with increased temperature and pH49. Unionized ammonia 
is a gas that can thus be released from the system49. Increased pH is achieved in facultative 
ponds by photosynthesis. Indeed, in highly photosynthetic ponds the pH can increase to 
 
  9 
values above 9.043. Photosynthetic algae also assimilate ammonia and nitrate directly43, 
which can further deplete wastewater of nitrogen in WSPs. 
 Phosphorus removal in WSPs occurs by two mechanisms: organic phosphorus is 
incorporated into algal and bacterial biomass and removed in effluent water, or phosphate 
precipitation under conditions with high pH43. The latter mechanism is more efficient if the 
pH is above 9.0, and is therefore more efficient in highly photosynthetic ponds, removing up 
to 80% of the phosphorus in very shallow ponds. However, in facultative ponds, the 
efficiency can substantially decrease to below 35% phosphorus removed43. 
1.3 Wastewater Treatment in the Canadian Arctic 
1.3.1 Factors Affecting Construction of Wastewater Treatment Plants 
Wastewater management in northern Canadian communities is limited due to the extreme 
climate of the Arctic. These communities also have relatively small populations and are 
isolated from the rest of Canada50,51. Because conventional WWTPs are not typically feasible 
to construct and operate in the Arctic, unique factors must be considered when establishing 
wastewater management facilities. Waste management solutions for the Arctic seek to 
minimize costs, prevent deterioration of water quality by eutrophication, and protect 
community members from potentially pathogenic microorganisms2,50. Most northern 
communities have a majority Inuit population, and many continue to follow traditions and 
regularly hunt and fish in the area. Many locals also collect their own drinking water directly 
from rivers which increases potential for exposure to pathogenic microorganisms48. 
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To combat these difficulties, many northern Canadian communities use facultative 
waste stabilization ponds, also referred to as sewage lagoons or wastewater lagoons, for 
wastewater treatment46,48. Wastewater is discharged directly into the environment, and 
treatment occurs passively through natural biological processes47. However, as described 
previously, Arctic WSPs are far less efficient than temperate WSPs due to sub-zero 
temperatures and limited sunlight for most of the year. Unfortunately, few studies have 
explored the efficiency of Arctic WSPs, and these systems are still poorly understood. There 
is also limited information about the microorganisms found in Arctic WSPs. 
1.3.2 Collection and Transport of Wastewater in Nunavut 
Many communities in Nunavut use a truck transportation system where sewage is collected 
directly from buildings. Each building is equipped with two separate storage tanks, one for 
the delivery of drinking water and another for wastewater collection52,53. The trucks remove 
wastewater from each building several times a week, and discharge it into the designated 
WSP where it remains frozen for approximately nine months of the year due to extremely 
cold temperatures of the region53. As the temperature increases in the spring, ice begins to 
thaw and wastewater moves into downstream lakes and streams. The wastewater can either 
be continuously discharged into downstream bodies of water or retained and discharged once 
per year. The temperature in the region remains above zero for approximately two to three 
months. This time period is collectively referred to as the treatment season, during which 
water temperature increases and longer periods of daylight occur48. The warmer conditions 
and increased light are more favourable for microorganisms to perform aerobic and anaerobic 
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degradation of organic matter and therefore remove potentially harmful materials from the 
water system45. 
The Canadian government has established strict guidelines for effluent water quality 
from wastewater systems. The current national standard for wastewater effluent requires that 
water not exceed a BOD of 25 mg/L, an average concentration of total suspended solids of 
25 mg/L, an average total residual chlorine of 0.02 mg/L, and an unionized ammonia 
concentration of 1.25 mg/L at 15°C54. Due to the factors precluding the construction of 
WWTPs, the Canadian government has exempted Nunavut from these regulations. Instead, 
Nunavut must ensure that wastewater does not exceed a maximum TSS of 180 mg/L, and 
BOD of 120 mg/L46. 
1.3.3 Microorganisms in Arctic Environments and Arctic Wastewater 
Numerous studies focusing on the microbial diversity of Arctic soil and permafrost have 
been done over the past 15 years55–61. Many studies agree that Actinobacteria is the dominant 
phylum present within permafrost-affected soil samples. It is thought that Actinobacteria are 
prevalent in these environments due to the ability of Actinobacteria species to form cysts, 
catabolize a wide range of carbon sources, and grow at low temperatures55,56. 
Due to the extreme climate of Arctic environments, microorganisms inhabiting Arctic 
water bodies require adaptations that allow them to remain viable in the frigid temperatures62. 
Although the diversity of Arctic microbial communities is still not fully understood, interest 
in climate change has increased focus on the microbiology of Arctic environments. For 
example, Yergeau and colleagues explored Canadian high-Arctic seawater and found that the 
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seawater was dominated by operational taxonomic units (OTUs) affiliated with 
Nitrosopumilus, Flavobacteriales, and Oceanospirillaceae63. However, the dominant taxa in 
these samples made up less than 60% of the predicted microbial community at the sampled 
sites63. Cyanobacteria are also highly abundant in Arctic freshwater and play an important 
role as primary producers 64. An Arctic freshwater lake in Alaska was dominated by 
members of the Actinobacteria, Betaproteobacteria, Bacteroidetes, and Alphaproteobacteria, 
which made up approximately 80% of the detected bacterial community65. 
Microorganisms in Arctic WSPs are not well understood. One study by Gonzalez-
Martinez and coworkers identified several dominant OTUs in Arctic influent sewage. The 
most abundant OTUs were associated with the genera Trichococcus, Methylorosula, 
Polaromonas, and Arcobacter, as well as family members of Leptotrichiaceae, 
Comamonadaceae, Alcaligenaceae, and Holophagaceae66. Another study explored 20 
wastewater treatment plants in Denmark and revealed Tetrasphaera, Trichococcus, 
Candidatus Microthrix, Rhodoferax, and Rhodobacter as the most abundant genera in these 
activated sludge samples67.  
Waterborne diseases are thought to be more prevalent in Arctic Canada in comparison 
to other parts of Canada50. Although WSPs are able to efficiently remove pathogens in 
warmer climate locations, relatively little is known about the ability of Arctic WSPs to 
remove pathogenic microorganisms68. Outbreaks of waterborne diseases are common in 
Arctic communities. Pathogens, such as enterohemorrhagic Escherichia coli O157:H7, 
Salmonella spp., Campylobacter spp., and Helicobacter pylori, have been detected in 
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community water supplies and stool samples48. This contamination may have been caused by 
the inability of current wastewater treatment systems to remove pathogenic microorganisms.  
The limited number of studies done in Arctic environments has only just begun to 
elucidate the microbiomes and the ability of Arctic WSPs to remove wastewater-associated 
microorganisms. Understanding the microbiota of WSPs and their downstream water bodies 
is important for characterizing the impact of wastewater discharge on the environment and 
local community, as well as predicting the impacts of future infrastructure upgrades on Arctic 
WSP performance. 
1.4 Microbial Community Analysis 
Studying the microbial communities of wastewater can help with monitoring of wastewater 
management and determining the effectiveness of treatment systems. Identifying dominant 
microorganisms in wastewater, as well as determining the presence of potential pathogens, 
aides with the construction of safer wastewater management systems for Arctic communities. 
With the improvements in DNA sequencing technologies over the past few decades, studying 
microbial diversity has become easier69. Various methods and pipelines have been developed 
to simplify the analysis of microbial communities. In particular, amplicon and metagenome 
sequencing are two very useful approaches for profiling microbial communities70,71.  
1.4.1 16S rRNA Gene Amplicon Sequencing 
Amplification and sequencing of the 16S rRNA genes is commonplace for microbial 
community characterization because of its universal distribution among prokaryotes and 
relatively slow evolution of the gene sequence72. Although much of the 16S rRNA gene is 
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highly conserved, there are nine variable regions that can be used to distinguish different 
species of bacteria and archaea73. Although the entire 16S rRNA gene can be sequenced, it is 
also reasonable to amplify a smaller portion of the gene using PCR to produce amplicons that 
can be subsequently sequenced70. This is a targeted approach for profiling microorganisms in 
communities from many samples, without sequencing entire genomes of constituent 
members74.  
Post-sequencing analyses of amplicons involves comparing sequences to a database 
of 16S rRNA gene sequences, such as the SILVA database75, and assigning taxonomy based 
on the best database hit. A frequently used analytical pipeline for this task is Quantitative 
Insights into Microbial Ecology version 2 (QIIME2), combined with a denoising and error 
correction tool called DADA276,77. Using these tools, it is possible to distinguish 16S rRNA 
gene amplicons into amplicon sequence variants (ASVs), which are unique sequences that 
differ by as little as one nucleotide78. The relative abundance of microorganisms can then be 
compared between different samples and locations by multivariate statistical approaches to 
identify significant differences in community composition. 
1.4.2 Metagenome Sequencing 
Metagenome sequencing is another common method for studying microbial communities. A 
metagenome is produced by sequencing all of the genetic material from a single sample79. In 
this approach, metagenomic DNA is sequenced, followed by analysis, and/or assembled and 
binned into metagenome-assembled genomes (MAGs). Several computational tools have 
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been developed for metagenome sequence analysis, such as ATLAS80, which performs the 
assembly, annotation, and binning of metagenome sequences80.  
The ATLAS pipeline first begins with quality control using various tools in the 
BBTools suite to remove adapters, filter and trim reads, and perform error correction81. In a 
typical pipeline, de novo assembly is then done using either MEGAHIT or metaSPAdes, 
followed by binning with metabat2, maxbin2, or concoct82–87. Binning involves grouping 
contigs that belong together to make up the genomes of single populations88. The DASTool 
software is also available as a final binner that compares outputs from each of the binning 
approaches used to produce high quality bins89. Once final bins are established, dRep is used 
to select the best bin for each MAG90. Functional annotation is then performed using 
Prodigal for identifying open reading frames (ORFs), which are translated and mapped to the 
eggNOG catalogue using DIAMOND to identify genes91–93. Finally, taxonomy is inferred 
using BAT to map genes to GenBank94,95. 
1.5 Thesis Objectives 
Currently there is a large gap in knowledge regarding the microbial communities of Arctic 
wastewater, specifically microorganisms associated with Arctic WSPs. This study aims to 
identify the major taxa in a representative Arctic WSP systems in Baker Lake, Nunavut to 
establish a baseline characterization and test the hypothesis that wastewater-associated 
microorganisms are enriched in wastewater and receiving waters relative to reference lakes, 
and determine whether these organisms are detected downstream of the WSP. This research 
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will also identify and relatively quantify antibiotic resistance genes within metagenomes and 
observe the prevalence of ARGs in the WSPs in comparison to downstream sites. 
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Chapter 2 
Methods 
2.1 Study Locations 
This study sampled the microbial communities of wastewater lagoons and receiving waters in 
three traditional indigenous territories in Nunavut (Figure 2.1): Baker Lake, Cambridge Bay, 
and Kugluktuk. The main focus was on Baker Lake with comparisons to the WSPs in 
Cambridge Bay and Kugluktuk. The territory of Nunavut has a population of about 37,000 
people in 25 communities, with populations ranging from about 150 to 7,500 people per 
community. Baker Lake, Cambridge Bay and Kugluktuk have populations of approximately 
2,000, 1,700, and 1,600 people, respectively96. 
Figure 2.1: Map of study locations in Nunavut, Canada. This map was adapted from Google 
Maps97. 
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2.1.1 Baker Lake, Nunavut 
Baker Lake is the only inland community in Nunavut, located west of Hudson’s Bay in the 
Kivalliq region. In Baker Lake, trucks collect wastewater from each building every two to 
three days and discharge it directly into the wastewater lagoon, located around one kilometre 
north of the community. The WSP freezes near the end of September and remains frozen 
until June. Over the nine months when temperatures are sub-zero, the wastewater 
accumulates in an ice block that spans a field leading down into Lagoon Lake. During the 
spring thaw in mid-June, water flow is relatively high and first flows into Lagoon Lake. 
From there, the water flows into Finger Lake, followed by Airplane Lake, and finally 
discharges into Baker Lake. There are two lakes upstream of Lagoon lake and one lake 
upstream of Airplane Lake that were used as reference sites that appear to be unaffected by 
the WSP. Sample collection was carried out at each of the major lakes downstream of the 
WSP in Baker Lake, Nunavut, as well as three reference lakes (Figure 2.2). Sampling 
occurred at two times points from July 13th-16th, 2018 and July 22nd-24th, 2018. Samples 
were labelled according to time points; samples containing the number “1” before site name 
belong to the group of samples collected July 13th-16, 2018, and samples containing the 
number “2” before site name correspond to the July 22nd-24th, 2018 sampling time point. 
Duplicates were indicated by an “A” or “B” following the site name in labels. For example, 
the first duplicate of the WSP at the first time point is labelled as 1WWLA. 
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Figure 2.2: Map of Baker Lake, Nunavut. Sampling sites are identified by yellow pins and labeled 
by sample name. Samples have been grouped by lakes as indicated by the coloured circles. Magenta 
is the Baker Lake wastewater lagoon, turquoise is Lagoon Lake, blue is Finger Lake, red is Airplane 
Lake, orange is Baker Lake, and green are the references. This map was adapted from Google Earth98.  
 
2.1.2 Cambridge Bay, Nunavut 
Cambridge Bay is located on Victoria Island in the Kitikmeot region of Nunavut. Throughout 
the year, wastewater is dumped into a WSP where primary treatment occurs. The wastewater 
is discharged once a year during the summer, where it passes through a natural tundra 
wetland that eventually leads into Cambridge Bay. The WSP is located approximately one 
kilometer north-east of the community. Samples were also taken from the WSP at Cambridge 
Bay for comparison at two time points on July 4th, 2018 and July 25th, 2018. WSP samples 
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samples, July 4th, 2018 samples contain a “1” before the site name and July 25th, 2018 
samples contain a “2” instead. Duplicates are distinguished by an “A” or “B” following the 
site name. 
2.1.3 Kugluktuk, Nunavut 
Kugluktuk is located at the mouth of the Coppermine River in the Kitikmeot region of 
Nunavut. The community dumps their wastewater into a single-cell, lined sewage lagoon. 
Similar to Cambridge Bay, the water is discharged once a year through a natural tundra 
wetland from the northwest corner of the lagoon. After passing through the wetland, the 
water flows into Coronation Gulf as the receiving water body. Samples were taken from the 
WSP at Kuglukluk at a single time point on August 16th, 2018. WSP samples from 
Kugluktuk were labelled as KWWL for the site name. Because only one time point was used, 
both sample labels contain a “1” before the site, and duplicates are distinguished with an “A” 
or “B” following the site name. 
2.2 Sample Collection and Environmental Data Collection 
Water from each sampling site was collected 4-5 m from the shoreline using a telescoping 
swing sampler and attached bottle to avoid disturbance of sediments. Samples were collected 
in duplicate from approximately 5-10 cm below the water’s surface. The bottle was rinsed 
multiple times at each sampling site before collecting water. The two sites ALE and BL at 
Baker Lake were only taken at a single time point due to limited access. For these sites, a 
boat was taken offshore and anchored. The ALE site samples were taken approximately 20 m 
offshore, whereas BL was taken approximately 300 m offshore. Water samples for these two 
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sites were collected using a sample bottle only at about 5-10 cm below the water’s surface. 
Water was filtered through a sterile 0.22 µm Sterivex-GV Pressure Filter Unit (EMD 
Millipore Corporation, MA, USA) using a 60-ml Luer-Lok Tip Syringe (Becton Dickinson, 
NJ, USA). Filtration was done until filter pores were plugged or a maximum of 500 ml was 
filtered. After filtration, residual water was expelled from the filter, leaving minimal amounts 
of water within the filter unit, then filter units were stored in Ziplock bags surrounded by ice 
packs. Samples were kept in a cooler and surrounded by frozen ice packs until delivered to 
the lab. Once received by the lab, samples were stored at -20°C until analyzed. 
Environmental data was also collected at each of the sampling sites. Latitude and 
Longitude were determined using the Gaia GPS app (TrailBehind Inc.). The PC100 Model 
pH/Conductivity Meter (Cole-Parmer, Montreal, Canada), was used to measure pH, 
conductivity, total dissolved solids, and salinity. Temperature was also measured on this 
meter using the pH probe. Dissolved oxygen was measured using the Traceable Dissolved 
Oxygen Pocket Tester with Calibration (Cole Parmer). 
2.3 DNA Extractions 
A summary of methods used to process environmental DNA samples in this study is shown 
in Figure 2.3. 
Filter unit housings were opened and filters removed aseptically. Each filter was cut in half, 
with one half stored at -20°C and the other half used for DNA extraction. Each half used for 
DNA extraction was cut into smaller pieces to increase extraction efficiency. Although all 
DNA extractions were done using the PowerSoil DNA Isolation Kit (MO BIO, CA, USA) 
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following the manufacturer’s instructions, PowerBead tubes were heated at 70°C for 10 
minutes prior to beadbeating with a FastPrep-24 (MP Biomedicals, CA, USA) at 5.5 m/s for 
45 seconds. Extraction kit negative controls were processed alongside samples and were 
“KC” followed by a number. Genomic DNA was quantified using a NanoDrop 2000 
(Thermo Scientific, MA, USA) and Qubit dsDNA High Sensitivity Assay Kit (Thermo 
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2.4 16S rRNA Gene Amplicon Library Preparation and Sequencing 
Using a modification of a previously published amplification and sequencing method99, the 
V4-V5 regions of the 16S rRNA gene were amplified from the genomic DNA extracts using 
primers 515F-Y/926R100,101. Each 25 µl PCR contained 2.5 µl of 10x ThermoPol Reaction 
Buffer (New England Biolabs, MA, USA), 1.5 µl of 10 mg/ml bovine serum albumin, 0.2 
µM 515F primer, 0.2 µM 926R primer, 0.2 mM dNTPs, 0.625 units of Taq DNA polymerase 
(New England Biolabs), 2-50 ng of genomic DNA as template in HyPure Molecular Biology 
Grade Water (GE Healthcare Life Sciences, UT, USA). Reactions were conducted in 
triplicate on a T100 Thermal Cycler (BioRad, CA, USA) or DNAEngine Peltier Thermal 
Cycler (BioRad) and conditions used for PCR were 95°C for 3 minutes, followed by 35 
cycles of 95°C for 30 seconds, 50°C for 30 seconds, and 68°C for 1 minute, finishing with 
68°C for 7 minutes. Samples were randomly assigned barcodes to avoid bias. 
Following PCR, triplicate PCR products were run separately on a 1% agarose gel then 
pooled. Equal amounts of DNA from each sample were combined prior to sequencing. Non-
template negative controls were added as 5 µl volumes, and positive controls were added at 
half the amount of the DNA samples. Negative controls were labelled as “NTC”. Positive 
controls contained equal amounts of Thermus aquaticus and Aliivibrio fischeri and were 
labelled as “PC”. Pooled samples were then run on another 1% agarose gel and bands 
corresponding to the 16S rRNA gene amplicons were extracted and purified using the 
Wizard SV Gel and PCR Clean-Up System (Promega, WI, USA). The eluted DNA library 
was stored at -20°C until further processing. 
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The library was prepared for sequencing on a MiSeq (Illumina, CA, USA) using the 
provided HT1 buffer to dilute the library to about 6 pM. The PhiX library was also added 
such that it made up 15% of the final library. Paired-end sequencing (2 x 250 bases) was 
performed on a MiSeq, generating ~18 million paired-end reads. Sequences are available in 
the Sequence Read Archive (SRA) at NCBI under accession number PRJNA600216 
(https://www.ncbi.nlm.nih.gov/sra/PRJNA600216). 
2.5 QIIME2 Analysis 
Paired-end reads were demultiplexed using the MiSeq Reporter software. Subsequent 
FASTQ files were imported into QIIME2, and adapter and primer sequences were removed 
using cutadapt102. Reads were then trimmed, denoised, dereplicated, and merged using 
DADA2 within QIIME2. Reads were trimmed based on a minimum quality score of 25 for 
the nucleotide position. This produced a feature table containing amplicon sequence variants 
(ASVs). The April 2018 SILVA release 132, 97% taxonomy classification for the 16S rRNA 
gene was used to train the Naïve Bayes classifier, and taxonomy was assigned to sequence 
variants within the feature table. The feature table was collapsed to the phylum level, and the 
uncollapsed ASV table was rarefied to a sampling depth based on the sample with the lowest 
number of reads and exported to visualize microbial community diversity in bar plots and 
bubble plots.  
A beta diversity analysis was conducted with scripts contained within the QIIME2 
pipeline. Phylogenetic trees were created using the ASV table and beta diversity analysis was 
performed using the same sampling depth as for rarefaction. Principal coordinates analysis 
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(PCoA) was performed using the weighted and unweighted UniFrac distance metrics. The 
PCoA results were visualized using a custom R script. 
2.6 Indicator Species Analysis 
Rarefied ASV tables exported from QIIME2 were used for an indicator species analysis 
(ISA)103, using only Baker Lake WSP samples, Lagoon Lake samples, and reference lake 
samples. The Baker Lake WSP and Lagoon Lake samples were assigned to one group, and 
reference lake samples were assigned to another group. Indicator species are species, or in 
this study, ASVs, that are associated with, or indicative of, an assigned group of samples104. 
Indicator values (IndVals) for each ASV within these samples were calculated using the 
multipatt function from the indicspecies R package105; 1000 permutations were tested to 
determine statistical significance. The ASVs with an IndVal of at least 0.9 and p value < 0.05 
were considered as indicator species and used for subsequent analysis and data 
visualizations. 
2.7 Metagenome Sequencing 
Genomic DNA was aliquoted for a subset of samples. Each sample location selected was 
sequenced in duplicate for all time points available. Sampling sites selected from Baker Lake 
included both time points and duplicates from WWL, LL, FLO, ALO, DWI, REF1, REF2. 
All available samples for the WSPs in Cambridge Bay and Kugluktuk were also sequenced. 
This gave a total of 34 samples that were aliquoted and sent to the Farncombe Metagenomics 
Facility at McMaster University for library preparation, quality control, and whole 
metagenome shotgun sequencing. The NEBNext Ultra II DNA Library Prep Kit (New 
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England Biolabs) was used to prepare the library for sequencing and paired-end sequencing 
(2 x 250 bases) was performed on two lanes of a HiSeq 1500 (Illumina) generating a total of 
~500 million paired-end reads. Sequences are available in the Sequence Read Archive (SRA) 
at NCBI under accession number PRJNA600216 
(https://www.ncbi.nlm.nih.gov/sra/PRJNA600216). 
2.8 MetAnnotate Analysis 
Raw metagenomic reads were analyzed using a development version of MetAnnotate106 
(available at https://github.com/MetAnnotate/MetAnnotate/tree/develop, commit ID: 
6e92c0e). A hidden Markov model (HMM) for the gene for the beta subunit of bacterial 
RNA polymerase (rpoB) was downloaded from the TIGRFAMs database107 and was used to 
profile the metagenomes by assigning taxonomy to reads identified as hits to the HMM. 
Forward and reverse reads were analyzed separately using HMM e values ≤ 1e-3 and RefSeq 
HMM e values ≤ 1e-6. Default values were used for all other parameters. The rpoB output 
table was then analyzed using a custom R script (available at 
https://github.com/jmtsuji/metannotate-analysis) to produce taxonomy abundance tables for 
comparison to 16S rRNA gene taxonomic assignments. Bar plots and bubble plots showing 
taxonomic profiles were produced with a custom R script.  
2.9 Metagenome Assembly and Binning 
Metagenomic reads were processed using the ATLAS release 2.0.6, which performs quality 
control, assembly, annotation, binning, and read mapping80. Quality control was performed 
by the BBtools suite81 tools to eliminate adapters, remove PCR duplicates, then trim and 
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filter reads based on quality scores and length of reads. Paired-end reads were assembled 
using the metaSPAdes84 assembly tool. Prodigal91 was used to predict ORFs in contigs and 
translated gene products were mapped to the eggNOG92 catalogue using DIAMOND93. 
Taxonomy was assigned using BAT94, mapping genes to the Genbank protein database95. 
Contigs were then binned using metabat285 and maxbin286, followed by DASTool89 as a final 
binner to dereplicate, aggregate, and score the bins and create high-quality metagenome-
assembled genomes (MAGs). Because some of the same genomes were identified in multiple 
samples, resulting in multiple bins for the same MAG, dRep90 was also used to select the best 
bin for each MAG. The MAG tables were then generated using a custom R script (available 
at https://github.com/jmtsuji/atlas2-helpers), and bar plots and bubble plots were produced 
with a separate custom R script.  
2.10 Mantel Test and Hierarchical Clustering 
The ASV tables, rpoB tables, and MAG tables were compared to one another with a Mantel 
test to assess correlations between the three datasets. Bray-Curtis dissimilarity matrices were 
produced for each of the three tables in R using the vegdist function in the vegan package108. 
The Mantel test was then performed on each pair of matrices using the mantel.rtest function 
from the ade4 R package109, with 1000 permutations to verify statistical significance. 
Hierarchichal clustering was then performed on each distance matrix using the hclust 
function in the stats R package110. The group average agglomeration method was used, which 
is equivalent to the unweighted pair-group method (UPGMA) whereby the distance between 
groups is calculated by averaging all of the distances for all pairs of individuals, assigning 
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one for each group111. Hierarchical clustering results for each dataset were plotted in 
dendrograms.  
2.11 Identification of ARGs using ShortBRED 
Forward and reverse reads from each set of paired-end metagenomic read files were analyzed 
separately to identify and quantify antibiotic resistance genes. This was done using the pre-
computed 2017 Antibiotic Resistance Factors marker collection from the ShortBRED36 
documentation pages (available at http://huttenhower.sph.harvard.edu/shortbred). This 
marker set is based on the CARD. The shortbred-quantify.py function from ShortBRED 
quantifies the relative abundance of each of the markers in the metagenomic reads. This 
function also normalizes the counts based on marker length and sequencing depth, giving a 
normalized count value in reads per kilobase of reference sequence per million sample reads 
(RPKM). Gene families were grouped manually into larger groups based on CARD 
information (Appendix 1). The tables of RPKM values were modified in a custom R script to 
factor in the gene family groupings and plotted in a heatmap with dendrograms produced by 
hierarchical clustering using the “ward.D2” agglomeration method. 
Groupings that appeared to be enriched in wastewater sites were examined in closer 
detail. The most abundant ARGs in the wastewater samples were selected as genes of 
interest, and reads from those samples were extracted for further investigation. The extracted 
reads were mapped to their contigs based on the metagenome assembles done previously. 
These contigs were then mapped to their bins, and the bins were then mapped to the MAGs 
to identify which MAGs contained the ARGs that were enriched in wastewater samples. 
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Chapter 3 
Results and Discussion 
Arctic wastewater systems are currently not well characterized, and the microbial 
communities of these systems are not well understood. This study aimed to develop a 
taxonomic profile of microorganisms within three Arctic WSPs and receiving waters in 
Baker Lake, Cambridge Bay, and Kugluktuk in the territory of Nunavut, with a focus on 
Baker Lake. To determine the major taxa present within Arctic wastewaters and verify the 
presence or absence of these groups in receiving waters, 16S rRNA gene amplicons and 
metagenomes were sequenced and taxonomy was assigned. Antibiotic resistance genes were 
also identified and quantified from metagenome sequences. The frequent misuse of 
antibiotics has created a growing problem of ARB, and this study aims to assess the 
enrichment of ARGs in wastewater, and determine if these ARGs are also accumulating in 
receiving waters. Overall, the research presented here will give a better understanding of the 
efficiency of WSP systems in Arctic conditions, and give insight into future improvements 
that can be made to the infrastructure of Baker Lake’s wastewater management system. 
3.1 Wastewater Treatment System of Baker Lake, Nunavut 
High-throughput 16S rRNA gene sequencing generated ~18 million paired-end reads, 
resulting in ~37,000 ASVs from all samples, including those from Cambridge Bay and 
Kugkluktuk, Nunavut. Read counts varied among samples, with a minimum read count of 
~19,000 reads and a maximum read count of ~310,000 (Table 3.1). Almost all negative 
controls, with the exception of one extraction kit control (KC3), had lower read counts and 
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possessed ASV profiles that were distinct from samples. Positive controls contained only 
Thermus aquaticus and Aliivibrio fischeri, as expected. All ASVs detected were used for 
ordinations using weighted and unweighted UniFrac distance metrics. Both weighted and 
unweighted UniFrac distances factor in phylogenetic distance of ASVs present in each 
sample. Weighted UniFrac distances also consider the abundance of these ASVs instead of 
just presence or absence. In later analyses, only ASVs with >0.1% abundance in WSP 
samples were included, excluding sample 2WWLB for filtering steps because it was 
considered an outlier based on relative abundances of phyla in that samples (Figure 3.2). This 
reduced the number of ASVs to 71 that were included in the analysis for the Baker Lake 
WSP. However, other lakes in Baker Lake contained more ASVs at >0.1% abundance that 
were not found in the WSP, and these ASVs were not studied in detail.  
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Table 3.1: 16S rRNA gene sequence read counts for all samples 






1WWLB 145,748 2WWLB 162,078 1KWWLB 59,544 
1LLA 87,581 2LLA 135,617 KC1 977 
1LLB 89,989 2LLB 155,740 KC2 1,048 
1FLIA 74,401 2FLIA 116,295 KC3 13,402 
1FLIB 110,023 2FLIB 71,642 KC4 491 
1FLOA 68,450 2FLOA 37,586 KC5 3,490 
1FLOB 190,174 2FLOB 98,601 PCa 112,403 
1ALIA 40,696 2ALIA 116,772 PCb 124,341 
1ALIB 51,116 2ALIB 104,529 PCc 167,680 
1ALOA 60,715 2ALOA 170,630 PCa2 170,665 
1ALOB 135,713 2ALOB 117,446 PCb2 168,867 
1ALEA 222,454 2ACOA 243,037 PCc2 260,504 
1ALEB 108,408 2ACOB 98,806 NTC1a 495 
1ACOA 309,507 2BLPA 38,480 NTC1b 254 
1ACOB 128,386 2BLPB 176,123 NTC1c 82 
1BLPA 95,702 2BLMA 58,054 NTC1a2 2,720 
1BLPB 135,337 2BLMB 130,378 NTC1b2 1,094 
1BLMA 195,020 2HCOA 33,895 NTC1c2 3,270 
1BLMB 239,541 2HCOB 77,445 NTC2a2 793 
1HCOA 219,146 2DWIA 36,393 NTC2b2 1,254 
1HCOB 84,125 2DWIB 154,192 NTC2c2 3,805 
1BLA 81,945 2BLCA 77,511 NTC3 1,020 
1BLB 57,651 2BLCB 148,365 NTC3a2 2,288 
1DWIA 94,338 2REF1A 108,036 NTC3b2 826 
1DWIB 68,186 2REF1B 127,099 NTC3c2 592 
1BLCA 19,131 2REF2A 109,562   
1BLCB 47,988 2REF2B 102,131   
1REF1A 72,729 2REF3A 85,693   
1REF1B 126,370 2REF3B 89,265   
1REF2A 100,937 1CBLA 164,233   
1REF2B 176,910 1CBLB 259,568   
1REF3A 47,514 2CBLA 132,595   
1REF3B 146,462 2CBLB 83,738     
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3.1.1 Temporal Variability  
Microbial community profiling of the wastewater treatment system in Baker Lake, Nunavut, 
as well as the receiving waters, identified changes in 16S rRNA gene profiles that were 
influenced by temporal and spatial factors. Specifically, ordinations based on both weighted 
and unweighted UniFrac metrics (Figure 3.1) demonstrated that samples from the first time 
point (July 13-16, 2018) separated from samples from the second time point (July 22-24, 
2018), with highly similar profiles for replicate samples. Greater variation in the data was 
explained by the first two ordination axes of the weighted distance metric (50.4%), compared 
to the unweighted distance metric (24.0%). Samples from Airplane Lake and Baker Lake 
substantially overlapped in ordination space (Figure 3.1). In general, there are many ASVs in 
common between these sets of samples. Particularly for the first time point, Airplane Lake 
and Baker Lake samples have very similar taxonomic profiles (Figure 3.4). This result was 
expected because incoming water from sources other than the WSP dilute the wastewater 
such that dominant wastewater microorganisms become less prevalent when mixed with 
upstream freshwater microbial communities.  
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Figure 3.1: Principal coordinates analysis (PCoA) using (A) weighted and (B) unweighted 
UniFrac distances based on amplicon sequence variants (ASVs) from 16S rRNA gene amplicons 
for sites in Baker Lake, Nunavut. 
 
A temporal shift in microbial community composition for most samples collected 
from the Baker Lake site is also reflected at the phylum level. Over the 10-day period 
between sampling time points, a shift in abundance of each phylum occurred for the majority 
of sample sites. Most sites shifted from being dominated by Bacteroidetes to containing 
higher levels of Actinobacteria, Cyanobacteria, and Verrucomicrobia (Figure 3.2). The most 
obvious shift occurred for samples collected from Finger Lake, Airplane Lake, and Baker 
Lake. In Airplane Lake and Baker Lake samples, members of the Bacteroidetes represented 
~75% of the detected microbial communities in samples from the first time point, yet 
decreased to as low as 4% relative abundance at some sampling sites. For samples collected 
at several of these sites, Cyanobacteria, Patescibacteria, Planctomycetes, and 
Verrucomicrobia were not detected, or were found at very low relative abundance for the 
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shift from being almost completely composed of Bacteroidetes and Proteobacteria, to 
containing far more Actinobacteria. This is particularly noticeable in the samples 2FLIA and 
2FLIB, which contained over 50% Actinobacteria despite the phylum not being detected at 
>1% relative abundance at the same site for the first time point (Figure 3.2). The Baker Lake 
WSP and Lagoon Lake samples were consistent temporally, with the exception of 2WWLB, 
which contained far more Firmicutes than any other Baker Lake samples. 
 
Figure 3.2: Relative abundance of phyla present at each site in Baker Lake, Nunavut. (A) 
Samples collected between July 13-16, 2018. (B) Samples collected between July 22-24, 2018. 
Sample names correspond to sites indicated on the map in Figure 2.2. Sample names beginning with 1 
correspond to samples collected during the first time point, and samples names beginning with 2 
correspond to samples collected during the second time point. Letters A and B at the end of sample 
names refer to replicates at the same site and time point. Corresponding lake names are indicated 
above bars. 
 
Many of the highly abundant ASVs that affiliated with the Bacteroidetes also 
belonged to the Flavobacteriaceae family (Figure 3.3), of which multiple species, 
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psychrophilic or psychrotolerant organisms112,113. There were two ASVs associated with 
Flavobacterium and Janthinobacterium that were more abundant at the first time point than 
the second time point, particularly for Airplane Lake, Baker Lake, and the reference lake 
samples. In particular, ASVs affiliated with Janthinobacterium were highly abundant in 
Baker Lake and reference lakes, but decreased in abundance for second time point samples 
(Figure 3.4). Strains of Janthinobacterium (within the Flavobacteriaceae family) have also 
been identified as psychrotolerant114,115. These psychrotolerant bacteria may have been 
present during the first sampling time point because water temperatures were still relatively 
cold. However, water temperatures gradually increased over the 10 days between sampling 
times. The most substantial temperature change occurred for the Baker Lake HCO site, 
increasing by 5°C over the 10-day period (Table A1). This temperature change may have 
impacted the microbial community because >60% of the community at the HCO site was 
dominated by Flavobacteriaceae, but this decreased to as low as 2% abundance for samples 
collected at the second time point (Figure 3.3). The increase in temperature may have 
induced the growth of other microorganisms, resulting in many low abundance organisms 





  36 
 
 
  37 
Figure 3.3: Relative abundance of families present at >0.1% abundance at each site in Baker 
Lake, Nunavut. (A) Samples collected between July 13-16, 2018. (B) Samples collected between 
July 22-24, 2018. Sample names correspond to sites indicated on the map in Figure 2.2. Sample 
names beginning with 1 correspond to samples collected during the first time point, and samples 
names beginning with 2 correspond to samples collected during the second time point. Letters A and 
B at the end of sample names refer to replicates at the same site and time point. Corresponding lake 
names are indicated above columns. 
 
  38 
 
 
  39 
Figure 3.4: Relative abundance of amplicon sequence variants (ASVs) present at >0.1% 
abundance at each site in Baker Lake, Nunavut. (A) Samples collected between July 13-16, 2018. 
(B) Samples collected between July 22-24, 2018. ASVs with <0.1% abundance in 1WWLA, 
1WWLB, and 2WWLA were not included. Samples that did not contain >0.1% abundance of any of 
these ASVs were not included. Sample names correspond to sites indicated on the map in Figure 2.2. 
Sample names beginning with 1 correspond to samples collected during the first time point, and 
samples names beginning with 2 correspond to samples collected during the second time point. 
Letters A and B at the end of sample names refer to replicates at the same site and time point. Lake 
names are indicated above columns. 
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3.1.2 Spatial Variability 
Taxonomic profiling of the WSP lakes system in Baker Lake also revealed spatial variations 
of the microbial communities in the WSP and downstream lakes. The weighted and 
unweighted UniFrac ordinations demonstrate that samples are broadly arranged based on 
their distance from the WSP (Figure 3.1). Sample sites that were geographically closer to the 
WSP also appeared closer to the WSP within ordination space, with reference sites grouping 
among the more distant sites, and this was consistent among replicates. Overall, spatial trends 
appear to be comparable between both ordinations with the exception of the WWL and LL 
samples, which grouped closer together on the unweighted UniFrac ordination, and separated 
from the other lakes (Figure 3.1).  
 Spatial variability was also apparent at the phylum level of community composition. 
Samples from the WSP had Proteobacteria comprising the majority of detected microbial 
communities, whereas downstream site samples had less Proteobacteria and more 
Bacteroidetes for the first time point. However, the second time point samples contained 
more Actinobacteria, Verrucomicrobia, and Planctomycetes in sites downstream of the WSP 
(Figure 3.2). Spatial variability was less apparent when visualized at the ASV and family 
levels (Figures 3.3 and 3.4). Focusing on microorganisms detected in the Baker Lake WSP at 
>0.1% abundance, many of the ASVs from the WSP samples were also present in Lagoon 
Lake samples, albeit at low abundance, but not detected at all in lakes further downstream 
(Figure 3.4). This may be due to dilution effects caused by inflowing water from the 
upstream reference lake into Lagoon Lake. At the family level, ~85% of microorganisms in 
the WSP appear to be related to Moraxellaceae and Pseudomonadaceae (Figure 3.3). Both of 
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these groups decreased to below 1% abundance in Lagoon Lake, which may have been 
caused by differences in both pH and temperature. The lower temperature, and higher pH in 
Lagoon Lake may have been less favourable to the bacteria affiliated with Moraxellaceae 
and Pseudomonas, and more favourable to other microorganisms, causing a shift in microbial 
community composition as water flowed from the WSP to Lagoon Lake. Lagoon Lake 
samples also appear to have multiple families in common with both the WSP samples as well 
as the upstream reference lakes (Figure 3.3). Flavobacteriaceae and Burkholderiacea were 
the two most abundant families shared by Lagoon Lake and the reference lakes. In 
comparison, the WSP contained both of these families in lower abundance than in both 
Lagoon Lake and the reference lakes. In general, the WSP and Lagoon Lake shared more 
families that were detected in lower abundance. Although Lagoon Lake receives water from 
both the WSP and upstream lakes and is expected to contain microbial inputs from both 
systems, the microorganisms detected in the WSP do not persist in higher abundance than the 
microorganisms found in the upstream reference lakes. Microorganisms introduced to the 
environment through the WSP and are likely outcompeted by the microorganisms that are 
naturally present in the environment.  
3.1.3 Wastewater Indicators 
An indicator species analysis (ISA) identified ASVs specific to WSP-associated samples. An 
ISA produces indicator values for each ASV found within each group, which are assigned 
prior to analysis. These indicator values are determined by calculating proportional 
abundance of an ASV across all groups followed by calculating proportional frequency of the 
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ASV in each group. These two proportions are combined and ASVs with the highest 
indicator values are considered to be indicator species for a specific group. Statistical 
significance is then calculated using a Monte Carlo test to determine whether the observed 
indicator values are higher than expected by chance111. Using indicator values >0.9 and p 
values <0.05, 46 ASVs were identified as indicator species for wastewater (Table 3.2). 
Several species of the genera associated with these ASVs were identified previously in 
wastewater, including Acinetobacter116, Trichococcus66, and Pseudomonas117,118. Other 
species have been identified in human fecal matter, including Bifidobacterium119, 
Ruminococcus119, and Enterococcus120. Although the majority of these ASVs were detected 
with greater than 10 reads in at least one sample, two ASVs associated with the genera 
Kaistia and Enterobacteriaceae had fewer than 10 reads in all samples (Figure 3.5). Out of 
the 46 indicator ASVs, 17 were identified at sites downstream of Lagoon Lake. However, 13 
of these indicator ASVs were found in a single site downstream of Lagoon Lake (i.e. 
2ACOB). This sample could be considered an outlier with potential WSP contamination 
because the replicate (i.e. 2ACOA) did not contain these same wastewater indicator ASVs, 
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Table 3.2: Indicator species analysis results for wastewater amplicon sequence variants (ASVs) 
in Baker Lake, Nunavut. WWL and LL samples were grouped and compared to REFx samples (x 
indicating lake number). ASVs with an IndVal >0.9 and p value <0.05 were included. Asterisks 







Taxonomic Affiliation IndVal p value 
Bifidobacterium_45* 1.000 0.001 
Pseudomonas_53* 1.000 0.001 
Trichococcus_90* 1.000 0.001 
Eubacteriaceae_100* 1.000 0.001 
Enterococcus_162* 1.000 0.001 
Bifidobacterium_185* 1.000 0.001 
Subdoligranulum_353* 1.000 0.001 
Eubacterium_356* 1.000 0.001 
Ettlia oleoabundans_390 1.000 0.001 
Erysipelotrichaceae_425 1.000 0.001 
Acetoanaerobium_439* 1.000 0.001 
Subdoligranulum_506 1.000 0.001 
Streptococcus salivarius subspp._542 1.000 0.001 
Tepidiphilus_557* 1.000 0.001 
Pleomorphomonas_815* 1.000 0.001 
Rhodobacteraceae_848 1.000 0.001 
Christensenellaceae_877 1.000 0.001 
Lactococcus lactis_881 1.000 0.001 
Pseudomonas_955* 1.000 0.001 
Akkermansia_1070 1.000 0.001 
Bifidobacterium_73* 1.000 0.001 
Psychrobacter_2* 1.000 0.001 
Acinetobacter_6* 0.997 0.004 
Acidovorax_36* 0.935 0.001 
Caulobacter_57 0.935 0.001 
Brevundimonas_191* 0.935 0.001 
Kaistia_290 0.935 0.001 
Rhodobacteraceae_402* 0.935 0.001 
Ruminococcus_504 0.935 0.001 
Holdemanella_508 0.935 0.002 
Rhodobacteraceae_618 0.935 0.001 
Akkermansia_659 0.935 0.001 
Catenibacterium_708 0.935 0.002 
Burkholderiaceae_849 0.935 0.001 
Proteiniclasticum_892 0.935 0.002 
Veillonellaceae_933 0.935 0.001 
Microbacterium_951 0.935 0.001 
Coprothermobacter_1051 0.935 0.001 
Methanobrevibacter_1110 0.935 0.001 
Anaerofilum_1139 0.935 0.002 
Sphingomonadaceae_1160 0.935 0.001 
Christensenellaceae_1178 0.935 0.001 
Gastranaerophilales_1229 0.935 0.001 
Enterobacteriaceae_1515 0.935 0.001 
Enterobacteriaceae_1638 0.935 0.001 
Pseudomonas_364* 0.933 0.001 
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Figure 3.5:Presence/absence heatmap of wastewater indicator amplicon sequence variants 
(ASVs) at all sites in Baker Lake, Nunavut. (A) Samples collected between July 13-16, 2018. (B) 
Samples collected between July 22-24, 2018. Sample names correspond to sites indicated on the map 
in Figure 2.2. Sample names beginning with 1 correspond to samples collected during the first time 
point, and samples names beginning with 2 correspond to samples collected during the second time 
point. Letters A and B at the end of sample names refer to replicates at the same site and time point. 
Lake names are indicated above columns. Boxes were filled in if the ASV had at least 10 reads at that 
site. 
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Although many of the indicator ASVs were detected at very low relative abundance, 
19 out of the 46 ASVs were detected at >0.1% abundance (Table 3.2 and Figure 3.4). Many 
of these ASVs were detected in the WSP or Lagoon Lake but were not found in downstream 
sites. This means that wastewater may not be impacting downstream sites as heavily as 
expected, and that dilution of the wastewater leaving the WSP may be enough to reduce 
wastewater organisms in downstream sites below detectable levels.  
A single wastewater indicator ASV was detected in reference lakes as well as in the 
WSP. This ASV was associated with the genus Acinetobacter and was detected in the WSP 
at ~60% relative abundance. Species within this genus are relatively ubiquitous121, and 
therefore it is not surprising that this ASV was detected in every lake examined, albeit at 
below 1% abundance for samples taken from most sites. This could be a potential health 
concern because a number of species within this genus are human pathogens and several of 
which have been associated with multi-drug resistant infections121,122. However, the source of 
this ASV cannot be directly associated with wastewaters because it was also found in 
samples from reference sites, which should have no wastewater input. Further testing would 
need to be done to identify the origin of this ASV. Species-level classification was not 
identified for the majority of ASVs, and therefore it is not possible to know whether this 
ASV was a potential pathogen, and further tests would also need to be performed to better 
characterize the Acinetobacter-affiliated taxa detected in the wastewater. 
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3.2 Comparison of WSPs from Baker Lake, Cambridge Bay, and Kugluktuk 
Ordinations prepared with WSP samples from Baker Lake, Cambridge Bay, and Kugluktuk 
demonstrated that samples grouped distinctly based on WSP location on both axes (Figure 
3.6), with the exception being that first time point Cambridge Bay WSP samples grouped 
with the Baker Lake WSP samples. The weighted UniFrac ordination grouped these samples 
closer together than the unweighted UniFrac ordination. In total, ~75.5% of the variance was 
explained on the first two axes of the weighted UniFrac ordination, compared to only ~46.7% 
of the variance explained on the first two axes of the unweighted UniFrac ordination. The 
weighted UniFrac ordination also separated the Baker Lake sample, 2WWLB, from the other 
Baker Lake samples. Sample 2WWLB was previously established as an outlier, so this trend 
was expected. The Kugluktuk samples also did not group with any other samples from 
different sampling sites (Figure 3.6). 
Figure 3.6: Principal coordinates analysis (PCoA) ordination plots using (A) weighted and (B) 
unweighted UniFrac distances based on amplicon sequence variants (ASVs) from 16S rRNA 
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Despite site-specific grouping within ordination space, samples from the three WSPs 
had similar taxonomic profiles, with Proteobacteria representing >75% of the microbial 
communities detected for all samples, except 2WWLB and the samples from the second time 
point of Cambridge Bay (Figure 3.7). As expected based on the ordinations, microbial 
community ASV profiles detected for Kugluktuk samples were distinct (Figure 3.8), with 
only two ASVs at >1% abundance in common for the other two locations. These two ASVs 
were associated with the genus Pseudorhodobacter, which was in common with the 
Cambridge Bay WSP and the genus Brevundimonas, which was shared with the Baker Lake 
WSP. The most abundant ASVs in the Kugluktuk WSP were affiliated with Acidovorax and 
Rhodoferax genera. Multiple strains of Acidovorax were reported for activated sludge 
samples from municipal WWTPs, and are known to be denitrifiers123,124. Strains of 
Rhodoferax have also been identified as denitrifiers involved in the removal of nitrogen in 
WWTPs125, and several strains have also been described as psychrotolerant126,127. It is likely 
that these samples contained a mixture of wastewater and sludge, indicating disturbance of 
the sediments within the WSP caused by the continuous dumping of new wastewater into the 
WSP. 
The first time point Cambridge Bay samples grouped more closely to samples from 
Baker Lake than to the second time point Cambridge Bay samples (Figures 3.6). The second 
time point Cambridge Bay samples contained more phyla than identified in the first time 
point, including Cyanobacteria, Planctomycetes, and Verrucomicrobia (Figure 3.7). 
Actinobacteria ASVs were also present in higher proportions for second time point 
Cambridge Bay samples than in the rest of the samples, apart from 2WWLB. Differences in 
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microbial community profiles for Cambridge Bay samples were likely linked to temporal 
factors. The first set of WSP samples from Cambridge Bay were collected prior to 
wastewater discharge and the second set of samples were collected after the initial release of 
wastewater had occurred. The lagoon became shallower as a result of the release, presumably 
allowing for a rapid water temperature increase. Previous research showed that 
Cyanobacteria increased in shallow lakes with higher temperature128, and thus may have 
proliferated in the Cambridge Bay WSP as water levels decreased. This same growth 
induction may have occurred for other microorganisms as temperatures increased. The 
dominant ASV for the first time point was associated with Psychrobacter, at a relative 
abundance of >80% (Figure 3.8), yet, this ASV was not detected in the second time point. 
Instead, ASVs associated with other genera became more prevalent such that none of the 
ASVs identified during the second time point were identified in the first at an abundance of 
>1%. Psychrobacter species have been identified as psychrophiles112 and a shift from colder 
to warmer temperatures is highly likely associated with these abundance changes. 
Unfortunately, temperature measurements were not taken for either time point due to 
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Figure 3.7: Relative abundance of phyla present at waste stabilization pond (WSP) sites in 
Baker Lake, Cambridge Bay, and Kugluktuk. (A) Samples collected from the WSP at Baker Lake. 
(B) Samples collected from the WSP at Cambridge Bay. (C) Samples collected from the WSP at 
Kugluktuk. Sample names beginning with 1 correspond to samples collected during the first time 
point, and samples names beginning with 2 correspond to samples collected during the second time 




























































































Figure 3.8: Relative abundance of amplicon sequence variants (ASVs) present at >1% 
abundance at waste stabilization pond (WSP) sites in Baker Lake, Cambridge Bay, and 
Kugluktuk. (A) Samples collected from the WSP at Baker Lake. (B) Samples collected from the 
WSP at Cambridge Bay. (C) Samples collected from the WSP at Kugluktuk. Sample names 
beginning with 1 correspond to samples collected during the first time point, and samples names 
beginning with 2 correspond to samples collected during the second time point. Letters A and B at the 
end of sample names refer to replicates at the same site and time point. 
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3.3 Comparison of 16S rRNA Genes and Metagenomes 
A subset of the samples that were analyzed to compare 16S rRNA gene profiles were 
selected for metagenomic sequencing, including a single sample from each of the lakes 
downstream of the Baker Lake WSP, as well as from the WSP itself. The sampling sites 
closest to the outflow of those lakes were selected. The DWI site in Baker Lake was selected 
because it is located near the water intake pipe for the community. Two out of the three 
reference sites were included for comparison. The Cambridge Bay and Kugluktuk WSP 
samples were also sequenced. For each of the sites selected from Baker Lake and Cambridge 
Bay, duplicates at both time points were sequenced. Because Kugluktuk only had a single 
time point sampled, there were only duplicates sequenced. 
 Metagenome sequencing generated ~600 million paired-end reads. Raw reads were 
analyzed using MetAnnotate106, which identified all sequences that matched with the rpoB 
gene HMM. This produced a microbial community profile that could be compared to the 16S 
rRNA gene profile. All reads were also assembled using the ATLAS 2.0 pipeline80, and 
MAGs were generated. The ATLAS 2.0 pipeline also assigns taxonomy to the MAGs based 
on taxonomic assignments to all binned genes. Although these profiles were also compared 
to the 16S rRNA gene profiles, only a portion of the reads were assigned to bins. This portion 
of unassigned reads varied between samples, ranging between 20-80% of reads. These reads 
were labelled as “unclassified” (Figures 3.10C-12C). Therefore, the MAG taxonomic profiles 
reflect a subset of DNA sequences obtained.  
 
 
  53 
3.3.1 Consistent Taxonomic Profiles 
Taxonomic profiles based on 16S rRNA gene amplicons, taxonomic assignments to 
sequences associated with rpoB, and taxonomic assignments to MAGs showed similar 
groupings of samples (Figure 3.9). Each of the ordinations display spatial variability with 
regards to geographic distance of sampling sites from one another. The WSP samples were 
more similar to sample sites located geographically closer to Baker Lake’s WSP samples 
than Airplane Lake, Baker Lake, and reference lake samples. This gradient was expected 
because wastewater entering the downstream lake systems is diluted, and therefore microbial 
communities associated with the wastewater are also diluted and outcompeted by other 
microorganisms. The Baker Lake WSP grouped closely with the first time point of the 
Cambridge Bay WSP, whereas the Kugluktuk WSP and the second time point of the 
Cambridge Bay WSP grouped more closely with Lagoon Lake and Finger Lake samples. 
Based on the phylum-level taxonomic profiles (Figures 3.10-12), this grouping was expected 
because similar proportions of each phyla were observed for samples that grouped together. 
 
 

























Figure 3.9: Principal coordinates analysis (PCoA) ordination plots using Bray-Curtis distances 
based on (A) amplicon sequence variants (ASVs) from 16S rRNA gene amplicons, (B) 
taxonomic assignments to metagenome sequences corresponding to the rpoB hidden Markov 
model (HMM), and (C) taxonomic assignments to metagenome-assembled genomes (MAGs). 
 
In general, similar proportions of phyla for the same samples occurred when 
comparing the 16S rRNA gene taxonomic assignments and rpoB gene taxonomic 
assignments (Figures 3.10-12). However, this pattern was not as clear when observing MAG 
taxonomic assignments. Only a small proportion of all metagenomic reads were assigned to 
bins, and therefore many reads were not classified. However, similar ratios of the phyla that 
were detected in each sample were still observed when comparing MAG taxonomic 
assignments to the other two datasets. Proteobacteria was the dominant phylum in WSP 
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phyla in the 16S rRNA gene taxonomic assignments as well as in the rpoB gene taxonomic 
assignments. However, these groups are underrepresented in the MAG taxonomic 
assignments, likely due to the low proportion of mapped reads. The only difference with the 
rpoB taxonomic classifications is that the Actinobacteria phylum was more prominent than 
displayed in the 16S rRNA gene taxonomic assignments. This is most noticeable in the first 
Baker Lake time point where relative abundance of the phylum is only as high as ~5% in the 
sample 1ALOA based on the 16S rRNA genes, but reaches up to ~30% for the same sample 
based on the rpoB gene (Figure 3.10). Forward and reverse metagenomic reads were used 
separately to identify taxa present based on the rpoB HMM. Both sets of reads also had 
consistent taxonomic profiles. 
Figure 3.10: Relative abundance of phyla present at metagenome sequenced sites from Baker 
Lake samples collected between July 13-16, 2018. (A) Taxonomic assignments to 16S rRNA gene 
amplicons. (B) Taxonomic assignments to sequences corresponding to the rpoB hidden Markov 
model (HMM). (C) Taxonomic assignments to metagenome-assembled genomes (MAGs). Sample 
names correspond to sites indicated in Figure 2.2. Letters A and B at the end of sample names refer to 
replicates at the same site and time point. R1 and R2 refer to forward and reverse reads, respectively. 
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Figure 3.11: Relative abundance of phyla present at metagenome sequenced sites from Baker 
Lake samples collected between July 22-24, 2018. (A) Taxonomic assignments to 16S rRNA gene 
amplicons. (B) Taxonomic assignments to sequences corresponding to the rpoB hidden Markov 
model. (C) Taxonomic assignments to metagenome-assembled genomes (MAGs). Sample names 
correspond to sites indicated in Figure 2.2. Letters A and B at the end of sample names refer to 
replicates at the same site and time point. R1 and R2 forward and reverse reads, respectively. Lake 
names are indicated above bars. 
Figure 3.12: Relative abundance of phyla present at metagenome sequenced sites from the 
WSPs in Cambridge Bay, and Kugluktuk. (A) Taxonomic assignments to 16S rRNA gene 
amplicons. (B) Taxonomic assignments to sequences corresponding to the rpoB hidden Markov 
model. (C) Taxonomic assignments to metagenome-assembled genomes (MAGs). Sample names 
correspond to sites indicated in Figure 2.2. Sample names beginning with 1 correspond to samples 
collected during the first time point, and samples names beginning with 2 correspond to samples 
collected during the second time point. Letters A and B at the end of sample names refer to replicates 
at the same site and time point. R1 and R2 refer to forward and reverse reads, respectively. Lake 
names are indicated above bars. 
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 Comparing these 16S rRNA gene, rpoB gene, and MAG datasets at the family level, 
the rpoB gene taxonomic assignment identified the most families (Figures 3.13-15). The 
rpoB gene taxonomic assignment identified 82 families, while only 56 were identified using 
the 16S rRNA gene, and 28 were identified using MAG taxonomy. Studies have shown that 
assigning taxonomy using rpoB gene amplicons allows for the identification of more 
species129,130. In this research, rpoB genes were identified using HMMs; however, the larger 
number of detected taxa may be attributed to rpoB providing better resolution among species, 
although this does not explain why bacteria from families such as Comamonadaceae were 
detected at relatively high abundance in the rpoB and MAG taxonomic assignment, but were 
not detected at all in the 16S rRNA gene analysis. However, the 16S rRNA gene analysis 
may have not detected the Comamonadaceae family due to primer bias against the 16S 
rRNA genes of the family. 
 Overall, seven of the most abundant taxa were identified in all three datasets, which 
includes Bifidobacteriaceae, Carnobacteriaceae, Caulobacteriaceae, Flavobacteriaceae, 
Moraxellaceae, Pseudomonadaceae, Rhodobacteraceae, and Sphingomonadaceae. 
Moraxellaceae was the dominant family in the Cambridge Bay WSP at the first time point as 
well as in both time points in the Baker Lake WSP. The Sphingomonadaceae family was 
highly abundant in Finger Lake samples, and Flavobacteriaceae was identified at high 
proportions in nearly all samples from Baker Lake. In contrast, Burkholderiaceae was 
identified in the 16S rRNA gene and rpoB gene analysis, but was not in the MAG taxonomy 
assignment. This may be due to the large number of reads that were not mapped to bins and 
thus many reads that were not assigned to a MAG may correspond to this family. This may 
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also have been caused by the inability to resolve taxonomic assignments to lower levels, and 
therefore some of the MAGs unresolved to the family level might also be associated with 
Burkholderiaceae, specifically those within the Burkholderiales order (Table 3.3). 
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Figure 3.13: Relative abundance of families present at >1% abundance in metagenome 
sequenced sites from Baker Lake, Cambridge Bay, and Kugluktuk, based on 16S rRNA gene 
amplicons. (A) Samples collected between July 13-16, 2018. (B) Samples collected between July 22-24, 
2018. (C) Samples collected from the Cambridge Bay and Kugluktuk waste stabilization ponds (WSPs). 
Baker Lake sample names correspond to sites indicated in Figure 2.2. Sample names beginning with 1 
correspond to samples collected during the first time point, and those beginning with 2 correspond to 
samples collected during the second time point. Letters A and B at the end of sample names refer to 
replicates at the same site and time point. Lake names are indicated above columns. 
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Figure 3.14: Relative abundance of families present at >1% abundance in metagenome 
sequenced sites from Baker Lake, Cambridge Bay, and Kugluktuk, based on taxonomic 
assignments to reads corresponding to the rpoB hidden Markov model (HMM). (A) Samples 
collected between July 13-16, 2018. (B) Samples collected between July 22-24, 2018. (C) Samples 
collected from the Cambridge Bay and Kugluktuk waste stabilization ponds (WSPs). Baker Lake sample 
names correspond to sites indicated in Figure 2.2. Sample names beginning with 1 correspond to samples 
collected during the first time point, and those beginning with 2 correspond to samples collected during the 
second time point. Letters A and B at the end of sample names refer to replicates at the same site and time 
point. R1 and R2 refer to forward and reverse reads, respectively. Lake names are indicated above 
columns. 
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Figure 3.15: Relative abundance of families present at metagenome sequenced sites from Baker 
Lake, Cambridge Bay, and Kugluktuk, based on taxonomic assignments to metagenome-
assembled genomes (MAGs). Samples collected between July 13-16, 2018. (B) Samples collected 
between July 22-24, 2018. (C) Samples collected from the Cambridge Bay and Kugluktuk waste 
stabilization ponds (WSPs). MAGs with unresolved taxonomic assignment at the family level were 
grouped into “Unresolved_MAGs”. Baker Lake sample names correspond to sites indicated in Figure 
2.2. Sample names beginning with 1 correspond to samples collected during the first time point, and 
samples names beginning with 2 correspond to samples collected during the second time point. A and 
B at the end of sample names refer to replicates at the same site and time point. Lake names are 
indicated above columns. 
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Table 3.3: Metagenome assembled genomes (MAGs) with unresolved family-level taxonomy. 
The entry with an asterisk indicates insufficient data for classification for the Bin Annotation Tool 




Taxonomic Affiliation MAG IDs 





2 Bacteroidetes MAG094;MAG109 
5 Betaproteobacteria MAG011;MAG033;MAG083;MAG091;MAG103; 





2 Clostridiales MAG018;MAG090 
2 Micrococcales MAG069;MAG133 
8 Planctomycetes MAG021;MAG046;MAG050;MAG053;MAG092; 
MAG106;MAG139;MAG140 
1 Rhizobiales MAG020 
6 Solirubrobacterales* MAG010;MAG026;MAG057;MAG113;MAG119; 
MAG142 
1 Sphingobacteriales MAG048 
3 Verrucomicrobia MAG047;MAG095;MAG123 
 
To determine how similar these three datasets are to one another, hierarchical 
clustering and the Mantel tests were conducted. The Mantel test determined, based on 
distance matrices for all samples from each dataset, that the rpoB dataset and 16S rRNA gene 
dataset were most similar, with a statistically significant observed correlation (Table 3.4). 
This is a strong positive correlation, indicating that samples within each dataset had similar 
distances to one another. The MAG dataset had a weaker correlation with the rpoB and 16S 
rRNA gene datasets (Table 3.4), but these were still considered significantly positive 
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correlations. Again, this is likely due to the underrepresentation of taxa in the MAG dataset 
as a result of fewer reads mapping to the MAGs.  
Table 3.4: Mantel test results comparing distance matrices for each pair based on 16S rRNA 
gene amplicons, taxonomic assignment to sequences corresponding to the rpoB hidden Markov 
model (HMM), and taxonomic assignment to metagenome-assembled genomes (MAGs). 
 
 
The average agglomeration method was used for hierarchical clustering of samples. 
Clustering performed using the single and complete agglomeration methods produced similar 
dendrograms. Although hierarchical clustering produced similar clusters of samples among 
different datasets, there were discrepancies in the clusters generated from the rpoB dataset in 
comparison to the other two datasets. The dendrograms all consistently clustered Baker Lake 
WSP samples with samples from the first time point from the Cambridge Bay WSP (Figure 
3.16). This trend was consistent across all analyses done, indicating that those samples were 
more similar to each other than to other samples, despite having few ASVs in common. 
Inconsistencies occur with Lagoon Lake samples that clustered with Baker Lake and 
reference lakes samples in the rpoB dendrogram, but clustered more closely with Kugluktuk 
WSP and Cambridge Bay WSP second time point samples in the other dendrograms. The 
family-level profile shows that Lagoon Lake samples had many families in common with the 




16S rRNA gene vs. 
rpoB gene 
16S rRNA gene vs. 
MAGs 
rpoB gene vs. 
MAGs 
Observed Correlation 0.83 0.63 0.52 
p value 0.001 0.001 0.001 
 



















Figure 3.16: Dendrograms based on hierarchical clustering done using the average 
agglomeration method and Bray-Curtis distances for (A) 16S rRNA gene amplicons, (B) 
taxonomic assignment to sequences corresponding to the rpoB hidden Markov model (HMM), 
and (C) taxonomic assignment to metagenome-assembled genomes (MAGs). Baker Lake sample 
names correspond to sites indicated in Figure 2.2. CBL refers to the Cambridge Bay waste 
stabilization pond (WSP). KWWL refers to the Kugluktuk WSP. Sample names beginning with 1 
correspond to samples collected during the first time point, and samples names beginning with 2 
correspond to samples collected during the second time point. Letters A and B at the end of sample 
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3.4 Antibiotic Resistance Genes in Metagenomes 
Antibiotic resistance genes were identified and quantified from metagenomic reads using 
ShortBRED36. The ShortBRED tool was used with pre-computed markers for ARGs based 
on the CARD to search through forward and reverse metagenomic reads separately and 
quantify relative abundances of ARG families within the reads. These relative abundances 
were normalized to RPKM and visualized (Figure 3.17). The RPKM values of forward and 
reverse reads for each sample were summed to determine which genes to use in downstream 
analyses.  
 Detection and quantification of antibiotic resistance genes from raw metagenomic 
reads revealed an enrichment of ARGs in WSP samples (Figure 3.17). The pre-computed 
ARG markers used were manually grouped into larger classes (Table A2). Although many 
sequences associated with the class “genes modulating resistance” were identified, the three 
WSPs and Lagoon Lake appeared to have an increased abundance of genes related to 
macrolide resistance, class A beta-lactamases, ABC-F ribosomal protection, and rRNA 
methyltransferases. Within these four ARG classes, nine genes were selected for further 
analysis because they were present at a level of >10 RPKMs in at least two sample sites 
(Table 3.5). Background abundances were calculated using all samples that did not cluster 
with the WSPs and Lagoon Lake, including both duplicates of the second time point from the 
Cambridge Bay WSP (Figure 3.17). The reads containing these nine gene families were 
mapped to bins associated with MAGs, and five MAGs were identified. Even though none of 
the bins that were associated with the MAGs that were selected as the best bin during 
dereplication, it is still possible that the representative best bins contain these genes. Further 
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investigation needs to be done to better connect the resistome to microbial community 
members.  
Four of the five ARG-containing MAGs were associated with genera that had been 
identified in the indicator species analysis (Table 3.2). These included Psychrobacter, 
Trichococcus, Acetoanaerobium, and Enterococcus (Table 3.6). The MAG associated with 
Psychrobacter (MAG030) was highly abundant in the Cambridge Bay WSP, whereas the 
other three MAGs associated with indicator species were found at much lower abundances. 
Although it has not been confirmed whether these bacteria contained the highly abundant 
ARGs, there is some evidence that wastewater indicator species encode ARGs. However, the 
wastewater indicators, as previously described, appear to be contained within the Baker Lake 
WSP and Lagoon Lake, and are only found at very low abundance at further downstream 
sites. Therefore, the Baker Lake WSP system may limit the spread of potentially pathogenic 





Figure 3.17: Heatmap of log10-transformed RPKM values of antibiotic resistance gene (ARG) families based on raw metagenomic reads. 
Baker Lake sample names correspond to sites indicated in Figure 2.2. CBL refers to the Cambridge Bay waste stabilization pond (WSP). KWWL 
refers to the Kugluktuk WSP. Sample names beginning with the number 1 correspond to samples collected during the first time point, and those 
beginning with the number 2 correspond to samples collected during the second time point. The letters A and B at the end of sample names refer to 
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Table 3.5: Abundant antibiotic resistance gene (ARG) families selected for downstream analysis. The RPKM values for forward and reverse 
reads from the same sampling site were summed. The RPKM ranges for duplicates were included for waste stabilization pond (WSP) and Lagoon 
Lake sampling sites that clustered together (Figure 3.17). Background abundances were also determined by calculating the average and standard 






















Class A Beta-Lactamase CARB-16 0 25.03-29.69 0 0 189.08-727.71 0-13.82 124.43-630.88 
rRNA Methyltransferase ermB 0 1.87-2.94 0 1.26-1.66 97.94-264.40 0-4.73 28.52-236.33 
rRNA Methyltransferase ermF 1.38 ± 4.02 0-2.50 0 71.78-77.04 204.94-307.13 0-26.09 3.43-5.03 
ABC-F Ribosomal Protection mefA 0 2.53-2.65 4.06-4.39 0 12.05-16.19 0 11.58-53.21 
ABC-F Ribosomal Protection mel 0 0-11.50 0 0 0-6.15 0 1.93-15.11 
Macrolide Resistance mphA 0 0-1.82 0-1.78 34.63-34.76 5.34-58.25 16.98-75.90 4.70-5.63 
Macrolide Resistance mphE 1.99 ± 7.93 1883.07-1918.60 115.00-164.04 21.80-25.77 964.03-2437.73 7.03-31.61 249.08-1213.86 
Macrolide Resistance mrx 0 0-1.59 0 11.89-19.68 4.74-35.69 10.24-40.80 5.22-6.96 
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Table 3.6: Metagenome-assembled genomes (MAGs) identified as being associated with bins 
that contain reads corresponding to antibiotic resistance genes (ARGs). Asterisks indicate 
taxonomic classifications that were previously identified as wastewater indicator organisms. 
 
MAG ID Associated Taxonomy 
MAG030 Psychrobacter* 
MAG040 Trichococcus* 




Of the nine most abundant ARG families (Table 3.5), all but CARB-16 confer 
resistance to macrolide antibiotics. These ARG families were found in higher abundances in 
Baker Lake WSP samples than in other WSP and Lagoon Lake samples (Table 3.5). 
Macrolide antibiotics have been used to treat clinical infections for several decades131 and are 
most commonly used to treat infections of the upper respiratory tract and skin infections132. 
In 2016 there was an outbreak of whooping cough among community members in Baker 
Lake133. Currently, common treatment for whooping cough includes taking antibiotics such 
as azithromycin, clarithromycin, or erythromycin, all of which are macrolide antibiotics134. 
Although speculative, it is possible that Baker Lake residents were prescribed macrolide 
antibiotics to treat various illnesses, which may have included whooping cough, thus 
releasing low concentrations of antibiotics into the environment that accumulated over time. 
This may have caused selection of bacteria containing ARGs and transfer of these genes to 
other bacteria through HGT, thus creating an abundance of ARGs concentrated in the WSP. 
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The ARBs may also have the opportunity to transfer resistance genes to pathogenic bacteria, 
specifically human pathogens, which coexist with other ARB and ARGs in wastewater135.  
3.4.1 CARB-16 
CARB-16, also referred to as blaRTG-6, belongs to a group of Class A beta-lactamases that are 
able to hydrolyze carbenicillin136. This gene has been identified on the pKLH80 plasmid, 
which is able to replicate in strains of Acinetobacter and Psychrobacter137. The plasmid itself 
was isolated from a psychrotolerant strain of Psychrobacter maritimus from permafrost137. 
Bins associated with MAG030, but not picked as the representative bin, contained the most 
abundant ARGs (Table 3.5). This MAG was found to be associated with the genus 
Psychrobacter and was detected within the Baker Lake WSP but was not detected further 
downstream. Large proportions of Acinetobacter were also identified within the microbial 
community of the Baker Lake WSP. This is concerning as species of Acinetobacter have 
been identified as human pathogens121 and if Psychrobacter species containing resistance 
genes for CARB-16 are able to pass these genes onto Acinetobacter species, this could create 
an antibiotic resistant strain of a potential human pathogen. However, further investigation 
must be done in order to confirm the presence of a CARB-16 gene, and possibly the pKLH80 
plasmid itself, within the genome of a Psychrobacter species. 
3.4.2 ermB and ermF 
 Erm antibiotic resistance genes are a family of 23S methyltransferases that methylate 
the 23S rRNA gene, reducing the affinity of macrolide antibiotics to bacterial ribosomes138. 
 
  72 
The ermB gene is known to be induced by the presence of erythromycin139. Both ermB and 
ermF have been detected in various Enterococcus species, some of which are important 
human pathogens140,141. MAG080, corresponding to the genus Enterococcus, was associated 
with bins containing the most abundant ARGs (Table 3.6), and was also detected in the 
Baker Lake WSP. An ASV corresponding to Enterococcus was also identified as a 
wastewater indicator species (Figure 3.6). However, MAG080 and the indicator ASV 
corresponding to Enterococcus were not detected at sites downstream of the WSP, and 
therefore the WSP system may be removing potentially pathogenic species of Enterococcus 
from the lake system. Alternatively, dilution effects may be decreasing the abundance of this 
ASV to below detection limits.  
3.4.3 mefA and mel 
 The mefA and mel genes are a part of the same operon as mefE142. The most current 
version of the CARD classifies these genes under the same accession number, possibly due 
to their similarities in function and sequence. These genes encode ATP-binding cassette 
(ABC) ribosomal protection proteins that catalyze macrolide efflux142. However, the 
expression of mel is insufficient to confer resistance to macrolides and also requires mefE 
expression for efflux142. The mel gene was found in lower abundance than the other highly 
abundant ARGs (Table 3.5), which may be due to the lack of mefE, and therefore there is 
likely no resistance conferred to organisms within the metagenomes containing the mel gene. 
The mefA gene was also found in relatively low abundance compared to the other highly 
abundant ARGs. However, the mefE gene has also been described as a subclass of the mefA 
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gene143, suggesting that mefA and mefE may be the same gene. If this is the case, mel 
combined with mefA would be sufficient to confer resistance to macrolides. Further 
investigation must be done in order to determine if these genes were found within the same 
bacteria, whether they are able to cause resistance to macrolides together. 
3.4.4 mphE and msrE 
 The mphE and msrE genes have been found in close proximity on a plasmid in an 
Acinetobacter baumannii isolate144, as well as on plasmids found in Klebsiella pneumoniae, 
Escherichia coli, and Citrobacter freundii145. The mphE gene encodes a macrolide kinase 
that phosphorylates the 2’-hydroxyl group of macrolide antibiotics146. The msrE gene 
encodes an ABC ribosomal protection protein that protects ribosomes by binding to 
macrolides and reducing affinity of the antibiotics to the ribosomes147. These genes were 
found at similar abundance in the metagenomes of Baker Lake’s WSP, the first time point of 
Cambridge Bay’s WSP, Kugluktuk’s WSP and Lagoon Lake, which could be indicative of 
co-occurrence within the same bacteria, possibly on the same plasmids.  
3.4.5 mphA and mrx  
  The mphA gene encodes a macrolide 2’-phosphotransferase that inactivates 
macrolide antibiotics148. However, the protein encoded by the mrx gene is an unidentified 
hydrophobic protein148. Although the mrx gene no longer exists in the CARD, it has been 
found to occur on the same operon as mphA, and both genes are thought to be required for 
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macrolide resistance148,149. These two genes were also found at similar abundance to one 
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Chapter 4 
Conclusions and Future Directions 
The unique and frigid climate of Arctic environments provides the need for specialized 
wastewater treatment solutions. In general, the microbial communities of Arctic WSPs are 
not well understood. This research has provided important insight into the composition of 
microbial communities in Arctic WSPs through 16S rRNA gene amplicon and metagenome 
analysis. The dominant phylum identified within the WSPs was Proteobacteria, which was 
consistent across all three WSPs observed in this study, with high abundances of ASVs 
associated with the family Moraxellaceae in both Baker Lake and Cambridge Bay samples. 
These results were consistent across 16S rRNA gene amplicons, taxonomic assignments to 
sequences identified by the rpoB HMM and taxonomic assignments to MAGs. Despite these 
similarities across the different WSPs, at the ASV level, the microbial communities were 
found to be quite different, with very few overlapping ASVs. The dominant ASV in the 
Baker Lake WSP was Acinetobacter, which was found at >50% relative abundance, whereas 
Psychrobacter was the dominant ASV in the Cambridge Bay WSP, at >80% relative 
abundance. Although the Kugluktuk WSP did not have a single, dominant ASV at the family 
level, Burkholderiaceae and Caulobacteraceae were the most prominent families, according 
to 16S rRNA gene amplicons. This research demonstrated that, despite the many differences 
in community composition at the ASV level, wastewater from different locations contain 
common groups of bacteria that are distinct from other Arctic freshwater sites. Future 
research involving the three WSPs observed should aim to compare the downstream lake or 
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wetland systems of the WSPs in detail to determine the efficiency of each WSP in the 
removal of potentially harmful wastewater microorganisms.  
 This research characterized the microbial communities of Arctic wastewater, with a 
focus on the Baker Lake WSP system. Over the next five years, the Baker Lake WSP system 
will likely undergo infrastructure upgrades to improve the performance of the system in the 
removal of wastewater contaminants from the environment, in an attempt to meet 
government guidelines with respect to wastewater effluent standards. The research presented 
here reveals both spatial and temporal changes in microbial communities across the Baker 
Lake WSP and downstream lake systems (Figures 3.1-3.4). The microbial communities of 
sites located further downstream from the WSP are less similar to sites located closer to the 
WSP, as well as the WSP itself. Temporally, shifts in relative abundance were observed at 
the phylum level where ten days between sampling times produced very different taxonomic 
profiles. In lakes downstream of the WSP, microbial communities shifted from being 
dominated by microorganisms associated with Bacteroidetes, to containing higher levels of 
organisms associated with Actinobacteria, Cyanobacteria, Patescibacteria, and 
Verrucomicrobia. These patterns were consistent across the three different datasets, which 
was further confirmed with Mantel tests providing significant, positive correlations. This 
research has also shown that many wastewater indicator ASVs were not detected in 
downstream lakes, demonstrating that the WSP effluent dilutes effectively within 
downstream receiving waters. Future research should ideally test whether these results are 
consistent across a multi-year timeframe and in multiple seasons.  
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 Another important objective of this research was to identify and quantify antibiotic 
resistance genes within the three WSPs, as well as sites downstream of the Baker Lake WSP. 
Wastewater is known as a hotspot for ARG dissemination and evolution. This was further 
confirmed through this research, because an enrichment of ARGs was detected within WSP 
samples. This was consistent across all three WSPs. In particular, genes related to macrolide 
resistance were highly abundant in all three WSPs (Table 3.5). Although this may be related 
to the use of antibiotics within the local community, no information about the administration 
of antibiotics in Arctic communities was found. This research also displayed evidence of 
ARGs associated with specific MAGs within the metagenomes. Five MAGs were identified 
as being associated with bins that contained reads identified as ARG sequences. However, 
more evidence is required to better connect the genes identified with their respective hosts. 
This could be accomplished by sequencing plasmids and associating them with their host by 
observing DNA methylation patterns using methods proposed by Beaulaurier and 
colleagues150. Plasmids could also be assembled using the metaplasmidSPAdes tool151, which 
could potentially be incorporated into the ATLAS pipeline used in this research.  
 Overall, this research has demonstrated the composition of microbial communities in 
the Canadian Arctic, specifically focusing on the unique microbial assemblages in Arctic 
WSPs and associated freshwater lakes. The 16S rRNA gene amplicon and metagenome 
sequencing approaches allowed for in-depth profiling of the microbial communities. 
Although further research is required to be able to fully understand the microorganisms in 
Arctic wastewater, and the efficiency of WSPs in the removal of wastewater contaminants, 
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this study has provided a baseline characterization of microbial communities in Arctic WSPs 
which will aid the future development of a safe and effective wastewater treatment system 
for the Baker Lake community.  
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Table A1: Environmental data from sites in Baker Lake, Nunavut. Site names correspond to those on the map in Figure 2.2. Data from 
both sampling time points has been included. 
 
Site 





























REF1 64.33715 -95.96131 12.6 15.2 7.07 7.59 81.6 84.1 59.0 59.7 0.04 0.04 9.5 8.2 
REF2 64.336836 -96.016599 14.8 16.1 7.38 7.72 112.3 60.4 80.0 43.0 0.06 0.03 9.8 9.1 
REF3 64.33707 -96.02652 16.1 16.7 7.62 8.06 101.0 73.8 71.4 52.3 0.05 0.04 9.3 9.7 
DWI 64.31557 -96.01727 10.1 11.1 6.94 7.31 108.2 31.0 77.1 22.0 0.05 0.02 10.9 11.0 
HCO 64.31519 -96.01374 6.1 11.1 7.14 7.59 231 48.6 165 34.7 0.12 0.02 11.8 11.4 
BLM 64.311844 -95.993918 6.1 9.5 6.96 7.47 158.6 31.0 113 22.0 0.08 0.02 12.4 10.9 
BLP 64.30668 -95.96240 7.0 9.9 7.02 7.51 142.1 33.0 101 23.7 0.07 0.02 12.8 10.3 
ACO 64.30960 -95.97852 8.3 9.2 7.04 7.48 149.7 34.3 107 24.4 0.08 0.02 12.3 11.6 
ALO 64.31702 -95.97436 14.6 12.9 9.06 7.62 86.4 79.7 61.2 56.5 0.04 0.04 10.5 11.3 
ALI 64.32044 -95.97424 16.2 14.5 9.06 7.73 94.6 82.7 67.4 58.8 0.05 0.04 10.7 10.5 
FLI 64.32967 -95.99605 17.2 15.0 9.04 7.16 166.5 202 119 143 0.08 0.10 9.6 7.7 
FLO 64.32796 -95.98515 17.4 15.1 9.64 9.13 164 215 117 152 0.08 0.11 10.1 10.8 
LL 64.33113 -96.00263 16.1 17.6 9.40 8.95 188.0 289 134 205 0.09 0.14 14.3 10.3 
WWL 64.32971 -96.00595 18.7 21.3 7.84 7.79 928 1125 670 794 0.47 0.56 3.3 6.7 
BLC 64.31625 -96.04948 10.3 11.5 7.40 7.52 231 44.5 164 31.6 0.12 0.02 10.9 10.9 
BL 64.31300 -96.02019 6.2 N/A 7.42 N/A 64.2 N/A 45.5 N/A 0.03 N/A 10.7 N/A 




  95 
Table A2: Manually assigned resistance classes for gene families identified by ShortBRED for 
antibiotic resistance gene (ARG) families based on CARD gene family classifications including 
NCBI and CARD identifiers. 
Resistance Class NCBI Identifier CARD Identifier ARG Family 
Aminoglycoside Acetyltransferase AAA03550_1 3002523 AAC(2_)-Ia 
Aminoglycoside Acetyltransferase AAC44793_1 3002524 AAC(2_)-Ib 
Aminoglycoside Acetyltransferase CCP42991_1 3002525 AAC(2_)-Ic 
Aminoglycoside Acetyltransferase AAB41701_1 3002526 AAC(2_)-Id 
Aminoglycoside Acetyltransferase APB03221_1 3003988 AAC(2_)-IIb 
Aminoglycoside Acetyltransferase AAG15269_1 3002528 AAC(3)-Ia 
Aminoglycoside Acetyltransferase AAL82588_1 3002600 AAC(3)-Ib_AAC(6_)-Ib__ 
Aminoglycoside Acetyltransferase CAD53575_1 3002531 AAC(3)-Ic 
Aminoglycoside Acetyltransferase AAR21614_1 3002529 AAC(3)-Id 
Aminoglycoside Acetyltransferase AAA26548_1 3002534 AAC(3)-IIb 
Aminoglycoside Acetyltransferase CAA38525_1 3002535 AAC(3)-IIc 
Aminoglycoside Acetyltransferase CAA39184_1 3002536 AAC(3)-IIIa 
Aminoglycoside Acetyltransferase AAA25683_1 3002538 AAC(3)-IIIc 
Aminoglycoside Acetyltransferase ABB43029_1 3002539 AAC(3)-IV 
Aminoglycoside Acetyltransferase AAA25334_1 3002543 AAC(3)-IXa 
Aminoglycoside Acetyltransferase AAA16194_1 3002540 AAC(3)-VIa 
Aminoglycoside Acetyltransferase AAA88552_1 3002541 AAC(3)-VIIa 
Aminoglycoside Acetyltransferase AAA26685_1 3002542 AAC(3)-VIIIa 
Aminoglycoside Acetyltransferase BAA78619_1 3002544 AAC(3)-Xa 
Aminoglycoside Acetyltransferase AAK26252_2 3002583 AAC(6_)-29a 
Aminoglycoside Acetyltransferase CAE48335_2 3002599 AAC(6_)-30_AAC(6_)-Ib_ 
Aminoglycoside Acetyltransferase CAK55563_1 3002585 AAC(6_)-31 
Aminoglycoside Acetyltransferase ABR10839_1 3002586 AAC(6_)-32 
Aminoglycoside Acetyltransferase APB03223_1 3003989 AAC(6_)-34 
Aminoglycoside Acetyltransferase AAP43642_1 3002588 AAC(6_)-I30 
Aminoglycoside Acetyltransferase AAA98298_1 3002545 AAC(6_)-Ia 
Aminoglycoside Acetyltransferase NP_460578_1 3002571 AAC(6_)-Iaa 
Aminoglycoside Acetyltransferase BAD12078_1 3002572 AAC(6_)-Iad 
Aminoglycoside Acetyltransferase BAD14386_1 3002573 AAC(6_)-Iae 
Aminoglycoside Acetyltransferase ACI28880_1 3002575 AAC(6_)-Iai 
Aminoglycoside Acetyltransferase BAM46120_1 3003677 AAC(6_)-Iaj 
Aminoglycoside Acetyltransferase BAO21229_1 3003199 AAC(6_)-Iak 
Aminoglycoside Acetyltransferase BAD11815_1 3002593 AAC(6_)-Ib-SK 
Aminoglycoside Acetyltransferase AKN19287_1 3002578 AAC(6_)-Ib7 
Aminoglycoside Acetyltransferase AAA26549_1 3002549 AAC(6_)-Ic 
Aminoglycoside Acetyltransferase NP_863643_1 3002597 AAC(6_)-Ie-APH(2__)-Ia 
Aminoglycoside Acetyltransferase CAA39038_1 3002553 AAC(6_)-If 
Aminoglycoside Acetyltransferase AAA21889_1 3002554 AAC(6_)-Ig 
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Aminoglycoside Acetyltransferase AAB63533_1 3002556 AAC(6_)-Ii 
Aminoglycoside Acetyltransferase AAM92464_1 3002594 AAC(6_)-IIa 
Aminoglycoside Acetyltransferase AAA25680_1 3002595 AAC(6_)-IIb 
Aminoglycoside Acetyltransferase AAD46626_1 3002596 AAC(6_)-IIc 
Aminoglycoside Acetyltransferase CAE50925_1 3002589 AAC(6_)-Iid 
Aminoglycoside Acetyltransferase CAE50926_1 3002590 AAC(6_)-Iih 
Aminoglycoside Acetyltransferase AAC41392_1 3002557 AAC(6_)-Ij 
Aminoglycoside Acetyltransferase AAA87229_1 3002558 AAC(6_)-Ik 
Aminoglycoside Acetyltransferase AAK63041_1 3002559 AAC(6_)-Ip 
Aminoglycoside Acetyltransferase CAA91010_1 3002559 AAC(6_)-Ip 
Aminoglycoside Acetyltransferase AAC25500_1 3002560 AAC(6_)-Iq 
Aminoglycoside Acetyltransferase AAD03490_1 3002561 AAC(6_)-Ir 
Aminoglycoside Acetyltransferase AAD03491_1 3002562 AAC(6_)-Is 
Aminoglycoside Acetyltransferase BAD10948_2 3002563 AAC(6_)-Isa 
Aminoglycoside Acetyltransferase AAD03494_1 3002566 AAC(6_)-Iv 
Aminoglycoside Acetyltransferase AAD03495_1 3002567 AAC(6_)-Iw 
Aminoglycoside Nucleotidyltransferase AAU10334_1 3002628 aad(6) 
Aminoglycoside Nucleotidyltransferase YP_009081591_1 3002613 aadA13 
Aminoglycoside Nucleotidyltransferase CAI57696_1 3002614 aadA14 
Aminoglycoside Nucleotidyltransferase ACF17980_1 3002616 aadA16 
Aminoglycoside Nucleotidyltransferase AET15272_1 3003197 aadA25 
Aminoglycoside Nucleotidyltransferase AAF17880_1 3002605 aadA5 
Aminoglycoside Nucleotidyltransferase BAD00739_1 3002607 aadA7 
Aminoglycoside Nucleotidyltransferase ABG49324_1 3002609 aadA9 
Aminoglycoside Nucleotidyltransferase CAB14620_1 3002627 aadK 
Gene Modulating Resistance XP_753111_1 3003942 abcA 
MATE Transporter BAD89844_2 3000753 abeM 
SMR Antibiotic Efflux YP_002325052_1 3000768 abeS 
Class C Beta-Lactamase AAF86691_1 3001816 ACC-2 
RND Antibiotic Efflux NP_414995_1 3000216 acrB 
RND Antibiotic Efflux YP_490697_1 3000491 acrD 
RND Antibiotic Efflux AAC76297_1 3000499 acrE 
RND Antibiotic Efflux AAC76298_1 3000502 acrF 
RND Antibiotic Efflux AAC76296_1 3000656 acrS 
Class C Beta-Lactamase WP_004746565_1 3003848 ADC-2 
RND Antibiotic Efflux YP_002325610_1 3000774 adeA 
RND Antibiotic Efflux YP_002325611_1 3000775 adeB 
RND Antibiotic Efflux ALX99516_1 3003811 adeC 
RND Antibiotic Efflux YP_001706894_1 3000777 adeF 
RND Antibiotic Efflux YP_001706893_1 3000778 adeG 
RND Antibiotic Efflux YP_001713101_1 3000779 adeH 
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RND Antibiotic Efflux YP_002320475_1 3000780 adeI 
RND Antibiotic Efflux AAX14802_1 3000781 adeJ 
RND Antibiotic Efflux AAX14803_1 3000782 adeK 
RND Antibiotic Efflux ALH22601_1 3000620 adeL 
RND Antibiotic Efflux AGV28567_1 3000559 adeN 
RND Antibiotic Efflux ADM92605_1 3000553 adeR 
RND Antibiotic Efflux ADM92606_1 3000549 adeS 
Class A Beta-Lactamase AAC09015_1 3002481 AER-1 
Class B Beta-Lactamase CAQ53840_1 3000853 AIM-1 
RND Antibiotic Efflux NP_250709_1 3002982 amrA 
Aminoglycoside Nucleotidyltransferase AAC64365_1 3000230 ANT(2__)-Ia 
Aminoglycoside Nucleotidyltransferase AAL51021_2 3002598 ANT(3__)-Ii-AAC(6_)-IId 
Aminoglycoside Nucleotidyltransferase EEX02086 3004089 ANT(3__)-IIa 
Aminoglycoside Nucleotidyltransferase ENU91137 3004090 ANT(3__)-IIb 
Aminoglycoside Nucleotidyltransferase ENU37733 3004091 ANT(3__)-IIc 
Aminoglycoside Nucleotidyltransferase AAO83986_1 3002623 ANT(4_)-Ia 
Aminoglycoside Nucleotidyltransferase YP_006938491_1 3003905 ANT(4_)-Ib 
Aminoglycoside Nucleotidyltransferase AAA25717_1 3002624 ANT(4_)-IIa 
Aminoglycoside Nucleotidyltransferase AAM76670_1 3002625 ANT(4_)-IIb 
Aminoglycoside Nucleotidyltransferase YP_008997281_1 3002626 ANT(6)-Ia 
Aminoglycoside Nucleotidyltransferase AIJ27543_1 3002629 ANT(6)-Ib 
Aminoglycoside Nucleotidyltransferase CBH51824_1 3002629 ANT(6)-Ib 
Aminoglycoside Nucleotidyltransferase AFU35063_1 3002630 ANT(9)-Ia 
Gene Modulating Resistance NP_415611_1 3004049 fabG 
Gene Modulating Resistance NP_415804_1 3004045 fabI 
Aminoglycoside Phosphotransferase AAX38178_1 3002634 APH(2__)-Ie 
Aminoglycoside Phosphotransferase AGV10818_1 3002669 APH(2__)-Ig 
Aminoglycoside Phosphotransferase AAK63040_1 3002635 APH(2__)-IIa 
Aminoglycoside Phosphotransferase AAB49832_1 3002636 APH(2__)-IIIa 
Aminoglycoside Phosphotransferase CAA37605_1 3002638 APH(3__)-Ia 
Aminoglycoside Phosphotransferase ABK33456_1 3002639 APH(3__)-Ib 
Aminoglycoside Phosphotransferase ABC68330_1 3002640 APH(3__)-Ic 
Aminoglycoside Phosphotransferase CAE51638_1 3002641 APH(3_)-Ia 
Aminoglycoside Phosphotransferase AAA26412_1 3002642 APH(3_)-Ib 
Aminoglycoside Phosphotransferase WP_000572405_1 3002644 APH(3_)-IIa 
Aminoglycoside Phosphotransferase CAA62365_1 3002645 APH(3_)-IIb 
Aminoglycoside Phosphotransferase ADQ43421_1 3002646 APH(3_)-IIc 
Aminoglycoside Phosphotransferase AGV10830_1 3002647 APH(3_)-IIIa 
Aminoglycoside Phosphotransferase CAA27061_1 3002648 APH(3_)-IVa 
Aminoglycoside Phosphotransferase ENV34035 3004087 APH(3_)-IX 
Aminoglycoside Phosphotransferase AAA26699_1 3002649 APH(3_)-Va 
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Aminoglycoside Phosphotransferase AAC32025_1 3002650 APH(3_)-Vb 
Aminoglycoside Phosphotransferase AAB21326_1 3002651 APH(3_)-Vc 
Aminoglycoside Phosphotransferase AGI04227_1 3003687 APH(3_)-VI 
Aminoglycoside Phosphotransferase AAA76822_1 3002654 APH(3_)-VIIa 
Aminoglycoside Phosphotransferase EPF73263 3004086 APH(3_)-VIII 
Aminoglycoside Phosphotransferase CAA24743_1 3002655 APH(4)-Ia 
Aminoglycoside Phosphotransferase CAA52372_1 3002656 APH(4)-Ib 
Aminoglycoside Phosphotransferase CAA68516_1 3002657 APH(6)-Ia 
Aminoglycoside Phosphotransferase CAA29136_1 3002658 APH(6)-Ib 
Aminoglycoside Phosphotransferase CAA25854_1 3002659 APH(6)-Ic 
Aminoglycoside Phosphotransferase AAC23556_1 3002660 APH(6)-Id 
Aminoglycoside Phosphotransferase CAA27276_1 3002661 APH(7__)-Ia 
Aminoglycoside Phosphotransferase AAB58447_1 3002662 APH(9)-Ia 
Aminoglycoside Phosphotransferase AAB66655_1 3002663 APH(9)-Ib 
Other ARG CBL58181_1 3003918 apmA 
Class C Beta-Lactamase BAM76830_1 3002993 AQU-1 
MFS Antibiotic Efflux YP_001332362_1 3000838 arlR 
MFS Antibiotic Efflux YP_499945_1 3000839 arlS 
rRNA Methyltransferase ADC55560_1 3000858 armA 
RND Antibiotic Efflux NP_252408_1 3004056 ArmR 
Other ARG AAC75315_1 3002985 arnA 
Other ARG NP_252244 3002985 arnA 
Rifampin Resistance AAC05822_1 3002846 arr-1 
Rifampin Resistance AAC64366_1 3002847 arr-2 
Rifampin Resistance ABV26707_1 3002850 arr-5 
Rifampin Resistance CAZ48628_1 3002852 arr-7 
Rifampin Resistance AGC29882_1 3002853 arr-8 
Gene Modulating Resistance AAC76093_1 3002986 bacA 
Gene Modulating Resistance CAX52582_1 3003324 mprF 
Macrolide Resistance EEL41021_1 3003072 mphL 
Macrolide Resistance EOO80837_1 3003767 mphM 
RND Antibiotic Efflux YP_490321_1 3000828 baeR 
RND Antibiotic Efflux BAA15934_1 3000829 baeS 
Other ARG APB03218_1 3003984 BahA 
Gene Modulating Resistance AAL82403_1 3003297 gyrA 
Gene Modulating Resistance WP_005768149_1 3003302 gyrB 
Other ARG NP_253464_1 3003582 basR 
Other ARG AEX49906_1 3003583 basS 
Class B Beta-Lactamase AAA22562_1 3002878 BcII 
Gene Modulating Resistance AAA99504_1 3002987 bcrA 
Gene Modulating Resistance AAA99505_1 3002988 bcrB 
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Gene Modulating Resistance AAA99503_1 3003250 bcrC 
Class A Beta-Lactamase ACT09140_1 3002387 BEL-3 
Gene Modulating Resistance YP_003971446 3003730 ileS 
Class B Beta-Lactamase BAL75272_1 3000856 BJP-1 
Class A Beta-Lactamase AAR20595_1 3000090 BLA1 
Class B Beta-Lactamase WP_024565805_1 3000579 BlaB 
Class A Beta-Lactamase ABU39978_1 3000160 blaI 
Class A Beta-Lactamase ABU39979_1 3000217 blaR1 
MFS Antibiotic Efflux AAC36944_1 3003006 blt 
MFS Antibiotic Efflux AAA22277_1 3003007 bmr 
Gene Modulating Resistance Q8FW76 3003772 mprF 
Gene Modulating Resistance YP_002344422_1 3003789 gyrA 
Gene Modulating Resistance EEK14408_1 3003931 gyrA 
ABC-F Ribosomal Protection AAC32027_1 3002817 carA 
Class A Beta-Lactamase CCW43444_1 3002255 CARB-16 
Class A Beta-Lactamase AHJ02283_1 3003186 CARB-23 
Class A Beta-Lactamase AAB19430_2 3002242 CARB-3 
Class A Beta-Lactamase AAP22374_1 3002248 CARB-9 
Chloramphenicol Resistance AAA22081_1 3002670 cat 
Chloramphenicol Resistance AAA23018_1 3002670 cat 
Chloramphenicol Resistance AAA25655_1 3002670 cat 
Chloramphenicol Resistance AAA26613_1 3002670 cat 
Chloramphenicol Resistance AAB23649_1 3002670 cat 
Chloramphenicol Resistance AAL08441_1 3002670 cat 
Chloramphenicol Resistance AAQ63644_1 3002670 cat 
Chloramphenicol Resistance CAA63498_1 3002670 cat 
Chloramphenicol Resistance AAB53259_1 3002671 cat-TC 
Chloramphenicol Resistance AAA22289_1 3002672 cat86 
Chloramphenicol Resistance AAA73865_1 3002674 catB 
Chloramphenicol Resistance CAI47810_1 3003110 catB10 
Chloramphenicol Resistance NP_848167_1 3002675 catB2 
Chloramphenicol Resistance NP_249397_1 3002679 catB7 
Chloramphenicol Resistance YP_009077553_1 3002680 catB8 
Chloramphenicol Resistance AAL68645_1 3002681 catB9 
Chloramphenicol Resistance CAA37806_1 3002684 catII 
Chloramphenicol Resistance CAA30695_1 3002685 catIII 
Chloramphenicol Resistance AAB51421_1; 
AAF66228_1 
3002686 catP|catD 
Chloramphenicol Resistance AAA23215_1 3002687 catQ 
Chloramphenicol Resistance CAA52904_1 3002688 catS 
Chloramphenicol Resistance APB03217_1 3003983 CatU 
Class B Beta-Lactamase CAC87665_1 3000855 CAU-1 
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Class A Beta-Lactamase ACT97415_1 3002999 CblA-1 
Class B Beta-Lactamase AAA22904_1 3000578 CcrA 
MATE Transporter CAE00499_1 3003835 cdeA 
RND Antibiotic Efflux AAB58160_1 3003009 ceoA 
RND Antibiotic Efflux AAB58161_1 3003010 ceoB 
Class A Beta-Lactamase AAA21532_1 3003559 cepA 
Class C Beta-Lactamase CAA56561_1 3003553 CepS 
rRNA Methyltransferase CAL64019_1 3003441 cfrA 
Class A Beta-Lactamase ACT97371_1 3003097 CfxA6 
Class B Beta-Lactamase ABS29619_1 3000841 CGB-1 
Other ARG AAN28945 3003785 murA 
rRNA Methyltransferase AAS79458_1 3001302 chrB 
rRNA Methyltransferase WP_015735625_1 3003907 cipA 
rRNA Methyltransferase YP_001420189_1 3002814 clbA 
rRNA Methyltransferase YP_002773985_1 3002815 clbB 
rRNA Methyltransferase YP_174574_1 3002816 clbC 
Gene Modulating Resistance Q0SSM7 3003773 mprF 
Gene Modulating Resistance WP_009887863_1 3003357 EF-Tu 
Gene Modulating Resistance YP_001086469_1 3003995 gyrA 
RND Antibiotic Efflux ABS43901_1 3000783 cmeA 
RND Antibiotic Efflux ABS43151_1 3000784 cmeB 
RND Antibiotic Efflux BAO79432_1 3000785 cmeC 
RND Antibiotic Efflux YP_002343805_1 3000526 cmeR 
Chloramphenicol Resistance AAB36568_1 3002700 cmlv 
Class C Beta-Lactamase BAJ17544_1 3002069 CMY-59 
Class C Beta-Lactamase AAD50818_2 3002019 CMY-8 
Other ARG APB03224_1 3003994 cpaA 
Class B Beta-Lactamase AJP77054 3003716 CPS-1 
RND Antibiotic Efflux NP_312864_1 3000830 cpxA 
RND Antibiotic Efflux BAE77933_1 3000518 CRP 
Class A Beta-Lactamase CBW46935_1 3001959 CTX-M-100 
Class A Beta-Lactamase AEM44648_1 3001970 CTX-M-110 
Class A Beta-Lactamase BAP34782_1 3002008 CTX-M-151 
Class A Beta-Lactamase ABD73290_1 3001920 CTX-M-59 
Class A Beta-Lactamase AAV97957_1 3001933 CTX-M-72 
Glycopeptide Resistance AAN62561_1 3003970 D-Ala-D-Ala 
Glycopeptide Resistance YP_007652797_1 3001205 BRP(MBL) 
Gene Modulating Resistance CAC19929_1 3002854 dfrA1 
Gene Modulating Resistance AHG97174_1 3003011 dfrA10 
Gene Modulating Resistance AHW42429_1 3002858 dfrA12 
Gene Modulating Resistance ACI32877_1 3002859 dfrA14 
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Gene Modulating Resistance AHB39758_1 3003013 dfrA15 
Gene Modulating Resistance AAK60186_1 3003014 dfrA16 
Gene Modulating Resistance ABG91835_1 3002860 dfrA17 
Gene Modulating Resistance CAC81324_1 3003015 dfrA19 
Gene Modulating Resistance CAE53424_1 3003016 dfrA20 
Gene Modulating Resistance CAP69659_1 3003017 dfrA21 
Gene Modulating Resistance CAG34233_2 3003019 dfrA23 
Gene Modulating Resistance CAI99385_1 3002856 dfrA24 
Gene Modulating Resistance ABB71176_1 3003020 dfrA25 
Gene Modulating Resistance CAL48457_1 3002857 dfrA26 
Gene Modulating Resistance AAA25550_1 3003105 dfrA3 
Gene Modulating Resistance AHV80711_1 3002863 dfrA8 
Gene Modulating Resistance AAN41433_1 3002864 dfrB1 
Gene Modulating Resistance ACR57831_1 3003022 dfrB3 
Gene Modulating Resistance AAO04716_1 3002865 dfrC 
Gene Modulating Resistance AAA85213_1 3002866 dfrD 
Gene Modulating Resistance AAD01867_1 3002875 dfrE 
Gene Modulating Resistance AAD01868_1 3002867 dfrF 
Gene Modulating Resistance BAE15963_1 3002868 dfrG 
Class C Beta-Lactamase AIT76100_1 3002152 DHA-21 
Class B Beta-Lactamase AGC92784_1 3000848 DIM-1 
Class B Beta-Lactamase AAN32638_1 3000842 EBR-1 
Other ARG AHH86051_1 3004063 EdeQ 
MFS Antibiotic Efflux BAG75524_1 3003954 efmA 
MFS Antibiotic Efflux NP_217362_1 3003955 efpA 
Gene Modulating Resistance CDO61513_1 3003948 efrA 
Gene Modulating Resistance CDO61516_1 3003949 efrB 
MATE Transporter BAC11911_1 3003551 emeA 
MFS Antibiotic Efflux BAA16547_1 3000027 emrA 
MFS Antibiotic Efflux AAC75733_1 3000074 emrB 
MFS Antibiotic Efflux EFF04178_1 3000309 emrD 
MFS Antibiotic Efflux BAA11236_1 3000206 emrK 
MFS Antibiotic Efflux NP_417169_1 3000516 emrR 
MFS Antibiotic Efflux BAA11237_1 3000254 emrY 
General Bacterial Porin AAK11270_1 3003385 Omp36 
RND Antibiotic Efflux ABG77965_1 3004042 acrA 
Gene Modulating Resistance AFK58561_1 3003079 liaS 
Gene Modulating Resistance AFK58562_1 3003078 liaR 
Gene Modulating Resistance ALL09868 3003092 cls 
Gene Modulating Resistance YP_006374661_1 3003438 EF-Tu 
Macrolide Resistance AAC78336_1 3002826 EreA2 
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Macrolide Resistance CAA01212_1 3000363 EreB 
rRNA Methyltransferase AAC69328_1 3001265 Erm(30) 
rRNA Methyltransferase AAC69327_1 3000598 Erm(31) 
rRNA Methyltransferase NP_899170_1 3000599 Erm(33) 
rRNA Methyltransferase AAP74657_1 3000600 Erm(34) 
rRNA Methyltransferase AAK07612_1 3000604 Erm(35) 
rRNA Methyltransferase AAL68827_1 3000605 Erm(36) 
rRNA Methyltransferase CCP44758_1 3000392 Erm(37) 
rRNA Methyltransferase AAN86837_1 3000601 Erm(38) 
rRNA Methyltransferase AAR92235_1 3000602 Erm(39) 
rRNA Methyltransferase ABW06859_1 3000603 Erm(41) 
rRNA Methyltransferase CBY77552_1 3003106 Erm(42) 
rRNA Methyltransferase CCF55073_1 3003205 Erm(43) 
rRNA Methyltransferase CUU67654_1 3003971 erm(44) 
rRNA Methyltransferase ANZ79476_1 3003908 Erm(47) 
rRNA Methyltransferase YP_001315192_1 3000347 ErmA 
rRNA Methyltransferase AAF86219_1 3000375 ErmB 
rRNA Methyltransferase AAA98296_1 3000250 ErmC 
rRNA Methyltransferase AAA22597_1 3000495 ErmD 
rRNA Methyltransferase CAB60001_1 3000326 ErmE 
rRNA Methyltransferase AAA88675_1 3000498 ErmF 
rRNA Methyltransferase AAC37034_1 3000522 ErmG 
rRNA Methyltransferase AAC32026_1 3002823 ErmH 
rRNA Methyltransferase CAA66307_1 3000592 ErmN 
rRNA Methyltransferase AAA26779_1 3001303 ErmO 
rRNA Methyltransferase AAC36915_1 3000593 ErmQ 
rRNA Methyltransferase ALX06067_1 3000594 ErmR 
rRNA Methyltransferase AAA26742_1 3001304 ErmS 
rRNA Methyltransferase AAA98096_1 3000595 ErmT 
rRNA Methyltransferase CAA44667_1 3001305 ErmU 
rRNA Methyltransferase AAB51440_1 3002824 ErmV 
rRNA Methyltransferase BAA03402_1 3001306 ErmW 
rRNA Methyltransferase AAG03357_1 3000596 ErmX 
rRNA Methyltransferase BAB20748_1 3002825 ErmY 
RND Antibiotic Efflux AAC74603_2 3003378 marA 
Gene Modulating Antibiotic Efflux AAC77033_1 3003381 soxR 
Gene Modulating Resistance AAN82549_1 3003369 EF-Tu 
Other ARG AIL15701 3003775 murA 
Gene Modulating Resistance BAE77595_1 3003303 gyrB 
SMR Antibiotic Efflux CAA77936_1 3004039 emrE 
Gene Modulating Resistance CDJ72593 3003889 GlpT 
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Gene Modulating Resistance CDJ73208 3003890 UhpT 
Gene Modulating Resistance NP_312937_1 3003288 rpoB 
RND Antibiotic Efflux NP_414997_1 3003807 acrR 
Gene Modulating Resistance NP_415372_1 3003751 nfsA 
Gene Modulating Antibiotic Efflux NP_418486_1 3003511 soxS 
General Bacterial Porin YP_489201_1 3003390 ompF 
Gene Modulating Resistance YP_491362_1 3003386 folP 
Class B Beta-Lactamase AJP77085 3003717 ESP-1 
Gene Modulating Antibiotic Efflux NP_311275_1 3000832 evgA 
Gene Modulating Antibiotic Efflux AAC75429_1 3000833 evgS 
Class A Beta-Lactamase AAA26775_1 3003564 EXO 
MFS Antibiotic Efflux AFK80333_1 3001313 facT 
MFS Antibiotic Efflux NP_273367_1 3003961 farA 
MFS Antibiotic Efflux NP_273368_1 3003962 farB 
Class B Beta-Lactamase CAB96921_1 3000606 FEZ-1 
MFS Antibiotic Efflux AAG16656_1 3002705 floR 
Other ARG BAA32493_1 3000423 FomA 
Other ARG BAA32494_1 3000449 FomB 
Fosfomycin Resistance NP_249820_1 3000149 FosA 
Fosfomycin Resistance ACC85616_1 3002804 FosA2 
Fosfomycin Resistance BAP18892_1 3003210 FosA4 
Fosfomycin Resistance AJE60855_1 3003209 FosA5 
Fosfomycin Resistance NP_831795_1 3000172 FosB 
Fosfomycin Resistance YP_001715981_1 3000172 FosB 
Fosfomycin Resistance ADX95999_1 3002873 FosB3 
Fosfomycin Resistance CAA83855_1 3000380 FosC 
Fosfomycin Resistance BAJ10053_1 3002874 FosC2 
Fosfomycin Resistance BAO79518_1 3003207 FosK 
Fosfomycin Resistance CWV56762_1 3000198 FosX 
Class C Beta-Lactamase CAA71325_1 3002156 FOX-2 
Other ARG AAL12234_1 3003552 fusB 
Other ARG WP_011303797 3003731 fusD 
Other ARG CAA90432_1 3003026 fusH 
RND Antibiotic Efflux NP_417969_1 3003834 gadE 
RND Antibiotic Efflux ANK04027_1 3003838 gadW 
RND Antibiotic Efflux YP_491919_1 3000508 gadX 
Class A Beta-Lactamase ADZ48685_1 3002346 GES-17 
Class B Beta-Lactamase AIY26289_1 3003194 GIM-2 
Macrolide Resistance CAA11707_1 3000463 gimA 
Class B Beta-Lactamase AAF04458_1 3000850 GOB-1 
RND Antibiotic Efflux NP_459349_1 3000504 golS 
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Gene Modulating Antibiotic Efflux NP_309766_1 3000676 H-NS 
Gene Modulating Resistance WP_014065640_1 3003924 gyrA 
Gene Modulating Resistance WP_041918279_1 3003925 parC 
Class B Beta-Lactamase AMY61250_1 3004092 HMB-1 
MATE Transporter WP_014550864_1 3003953 hmrM 
MFS Antibiotic Efflux NP_207972_1 3003964 hp1181 
MATE Transporter NP_207975_1 3003965 hp1184 
Class A Beta-Lactamase ACX71212_1 3001860 IMI-3 
Class B Beta-Lactamase CAA71441_1 3003095 imiS 
Class B Beta-Lactamase ABC88434_1 3002213 IMP-22 
Class B Beta-Lactamase AEH41427_1 3002218 IMP-27 
Class B Beta-Lactamase AGS82587_1 3002222 IMP-31 
Class B Beta-Lactamase BAM38093_1 3002225 IMP-34 
Class B Beta-Lactamase AFP97028_1 3002228 IMP-37 
Class B Beta-Lactamase AIA58910_1 3002236 IMP-45 
Class B Beta-Lactamase AIT76110_1 3002239 IMP-48 
Class B Beta-Lactamase ADK25051_1 3002268 IND-12 
Class B Beta-Lactamase AAG29761_2 3002259 IND-3 
Class B Beta-Lactamase AAG29765_2 3002260 IND-4 
Class B Beta-Lactamase ACZ65153_1 3002265 IND-9 
Rifampin Resistance AAB41059_1 3002884 iri 
Class B Beta-Lactamase AAK38324_1 3000840 JOHN-1 
Other ARG NP_415222_1 3003841 kdpE 
Class B Beta-Lactamase BAF91108_1 3000847 KHM-1 
RND Antibiotic Efflux ABR75897_1 3003373 acrR 
RND Antibiotic Efflux ABR76005_1 3003380 ramR 
RND Antibiotic Efflux CAC41008_1 3004041 acrA 
Gene Modulating Resistance CDO13981_1 3003585 PhoP 
General Bacterial Porin YP_005226137_1 3003966 OmpK35 
General Bacterial Porin YP_005228001_1 3003968 OmpK36 
Class A Beta-Lactamase ACE62798_1 3002317 KPC-7 
Class B Beta-Lactamase CAB75346_1 3000582 L1 
Class D Beta-Lactamase CAA40146_1 3002997 LCR-1 
MFS Antibiotic Efflux NP_414618_4 3003843 leuO 
Gene Modulating Resistance NP_465220 3003770 mprF 
rRNA Methyltransferase APB03216_1 3003982 LlmA 
Gene Modulating Resistance CAB12062_1 3003028 lmrA 
Gene Modulating Resistance KIX81495_1 3002813 lmrB 
ABC-F Ribosomal Protection ABF66011_1 3002881 lmrC 
Gene Modulating Resistance ABF66027_1 3002882 lmrD 
MFS Antibiotic Efflux ABF33001_1 3003969 lmrP 
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Lincosamide Nucleotidyltransferase CAL44992_1 3002835 lnuA 
Lincosamide Nucleotidyltransferase AGI42804_1 3002836 lnuB 
Lincosamide Nucleotidyltransferase AAY32951_1 3002837 lnuC 
Lincosamide Nucleotidyltransferase ABR14060_1 3002838 lnuD 
Lincosamide Nucleotidyltransferase AGT57825 3003762 lnuE 
Lincosamide Nucleotidyltransferase CAD91132_1 3002839 lnuF 
Lincosamide Nucleotidyltransferase WP_002333496_1 3004085 lnuG 
Other ARG AJF82049_1 3003573 LpxA 
Other ARG AJF83452_1 3003574 LpxC 
Class A Beta-Lactamase ACH58980_1 3002482 LRA-1 
Class C Beta-Lactamase ACH58999_1 3002489 LRA-10 
Class B Beta-Lactamase ACH58990_1 3002511 LRA-12 
Class C Beta-Lactamase ACH58991_1 3002484 LRA-13 
Class B Beta-Lactamase ACH58994_1 3002512 LRA-17 
Class C Beta-Lactamase ACH58997_1 3002492 LRA-18 
Class B Beta-Lactamase ACH59005_1 3002513 LRA-19 
Class B Beta-Lactamase ACH58985_1 3002485 LRA-2 
Class B Beta-Lactamase ACH58987_1 3002510 LRA-3 
Class A Beta-Lactamase ACH59002_1 3002483 LRA-5 
Class B Beta-Lactamase ACH58998_1 3002486 LRA-7 
Class B Beta-Lactamase ACH58988_1 3002487 LRA-8 
MFS Antibiotic Efflux AAC43550_1 3003967 lrfA 
ABC-F Ribosomal Protection AAT46077_1 3000300 lsaA 
ABC-F Ribosomal Protection NP_899166_1 3003111 lsaB 
ABC-F Ribosomal Protection AEA37904_1 3003112 lsaC 
ABC-F Ribosomal Protection AFU35065_1 3003206 lsaE 
Gene Modulating Resistance AAV85981_1 3000533 macA 
Gene Modulating Resistance AAV85982_1 3000535 macB 
Gene Modulating Antibiotic Efflux YP_489794_1 3000263 marA 
Other ARG AKF16168 3003689 MCR-1 
MFS Antibiotic Efflux AFH35853_1 3001328 mdfA 
RND Antibiotic Efflux NP_459347_2 3000789 mdsA 
RND Antibiotic Efflux NP_459346_1 3000790 mdsB 
RND Antibiotic Efflux NP_459345_2 3000791 mdsC 
RND Antibiotic Efflux AAC75135_2 3000792 mdtA 
RND Antibiotic Efflux AAC75136_1 3000793 mdtB 
RND Antibiotic Efflux AAC75137_1 3000794 mdtC 
RND Antibiotic Efflux AAC75138_1 3001330 mdtD 
RND Antibiotic Efflux AAC76539_1 3000796 mdtF 
MFS Antibiotic Efflux YP_489321_1 3001329 mdtG 
MFS Antibiotic Efflux AAC74149_2 3001216 mdtH 
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MATE Transporter AML99881_1 3001327 mdtK 
MFS Antibiotic Efflux AAC76733_1 3001215 mdtL 
MFS Antibiotic Efflux AAC77293_1 3001214 mdtM 
MFS Antibiotic Efflux BAE78084_1 3003548 mdtN 
MFS Antibiotic Efflux BAE78083_1 3003549 mdtO 
MFS Antibiotic Efflux BAE78082_1 3003550 mdtP 
Penicillin-binding Protein AGC51118_1 3000617 mecA 
Penicillin-binding Protein BAI83385_1 3003440 mecB 
Penicillin-binding Protein WP_000725529_1 3001209 mecC 
Penicillin-binding Protein NP_373280_1 3000124 mecI 
Penicillin-binding Protein YP_001245420_1 3000215 mecR1 
ABC-F Ribosomal Protection YP_008997285_1 3000615 mefA 
MFS Antibiotic Efflux ACJ63262_1 3003107 mefB 
MFS Antibiotic Efflux BAL43360 3003745 mefC 
MFS Antibiotic Efflux NP_358565_1 3000614 mefE 
ABC-F Ribosomal Protection YP_002743273_1 3000616 mel 
MATE Transporter AAU95768_1 3000026 mepA 
MATE Transporter YP_001440920_1 3000746 mepR 
RND Antibiotic Efflux NP_249116_1 3000377 MexA 
RND Antibiotic Efflux AAA74437_1 3000378 MexB 
RND Antibiotic Efflux AAB41956_1 3000800 MexC 
RND Antibiotic Efflux AAB41957_1 3000801 MexD 
RND Antibiotic Efflux NP_251183_1 3000803 MexE 
RND Antibiotic Efflux NP_251184_1 3000804 MexF 
RND Antibiotic Efflux NP_252894_1 3000806 mexG 
RND Antibiotic Efflux NP_252895_1 3000807 mexH 
RND Antibiotic Efflux NP_252896_1 3000808 mexI 
RND Antibiotic Efflux NP_252367_1 3003692 mexJ 
RND Antibiotic Efflux AAG07064_1 3003693 mexK 
RND Antibiotic Efflux NP_252368_1 3003710 mexL 
RND Antibiotic Efflux BAE06005_1 3003704 mexM 
RND Antibiotic Efflux BAE06006_1 3003705 mexN 
RND Antibiotic Efflux BAE06007_1 3003698 mexP 
RND Antibiotic Efflux BAE06008_1 3003699 mexQ 
RND Antibiotic Efflux NP_249115_1 3000506 mexR 
RND Antibiotic Efflux ADT64081_1 3000813 MexS 
RND Antibiotic Efflux NP_251182_1 3000814 MexT 
RND Antibiotic Efflux AAG07762_1 3003030 mexV 
RND Antibiotic Efflux AAG07763_1 3003031 mexW 
RND Antibiotic Efflux BAA34300_1 3003033 mexY 
RND Antibiotic Efflux NP_250710_1 3003709 mexZ 
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Quinolone Resistance NP_415632_1 3003844 mfd 
Quinolone Resistance CCP46182_1 3003035 mfpA 
Gene Modulating Antibiotic Efflux YP_003281576_1 3000815 mgrA 
Macrolide Resistance ABA28305_2 3000462 mgtA 
Class A Beta-Lactamase AIT76113_1 3002174 MIR-9 
Gene Modulating Resistance YP_007503908_1 3003306 gyrB 
Class A Beta-Lactamase ACS44784_1 3002185 MOX-6 
Class D Beta-Lactamase WP_042649345 3002191 MOX-9 
Macrolide Resistance BAA03776_1 3000316 mphA 
Macrolide Resistance BAA12910_1 3000318 mphB 
Macrolide Resistance CAJ51085_1 3000319 mphC 
Macrolide Resistance ANP63073_1 3003741 mphE 
Macrolide Resistance WP_010550189_1 3003071 mphE 
Macrolide Resistance BAL43359 3003742 mphG 
Macrolide Resistance APB03226_1 3003991 mphI 
Macrolide Resistance AAS13767_1 3003839 Mrx 
Gene Modulating Resistance NP_415434_1 3003950 msbA 
Class B Beta-Lactamase AJP77057 3003718 MSI-1 
Class B Beta-Lactamase AJP77058 3003719 MSI-OXA 
ABC-F Ribosomal Protection CCQ20328_1 3000251 msrA 
ABC-F Ribosomal Protection NP_416292_1 3002818 msrB 
ABC-F Ribosomal Protection AAK01167_1 3002819 msrC 
ABC-F Ribosomal Protection YP_724476_1 3003109 msrE 
RND Antibiotic Efflux CCP46065_1 3000816 mtrA 
RND Antibiotic Efflux NP_274719_1 3000810 mtrC 
RND Antibiotic Efflux NP_274718_1 3000811 mtrD 
RND Antibiotic Efflux CAA64891_1 3000812 mtrE 
RND Antibiotic Efflux YP_002002225_1 3000817 mtrR 
Class B Beta-Lactamase WP_063860852 3003842 MUS-2 
RND Antibiotic Efflux NP_251218_1 3004073 MuxA 
RND Antibiotic Efflux NP_251217_1 3004074 MuxB 
RND Antibiotic Efflux NP_251216_1 3004075 MuxC 
RND Antibiotic Efflux NP_253005_1 3004069 MvaT 
Gene Modulating Resistance AAK44936_1 3003395 rpsL 
Gene Modulating Resistance AAK46002_1 3003445 tlyA 
Gene Modulating Resistance AAK48336_1 3003458 ethA 
Gene Modulating Resistance AFN51819_1 3003327 embC 
Gene Modulating Resistance AFN51820_1 3003453 embA 
Gene Modulating Resistance CAA55486_1 3003459 gyrB 
Gene Modulating Resistance CAC29732_1 3003389 folP 
Gene Modulating Resistance CAC30845_1 3003284 rpoB 
 
  108 
Other ARG CCE36834 3003784 murA 
Gene Modulating Resistance CCP42728_1 3003295 gyrA 
Gene Modulating Resistance CCP43072_1 3003448 iniA 
Gene Modulating Resistance CCP43073_1 3003451 iniC 
Gene Modulating Resistance CCP44023_1 3003455 embR 
Gene Modulating Resistance CCP44244_1 3003393 inhA 
Gene Modulating Resistance CCP44620_1 3003461 ndh 
Gene Modulating Resistance CCP44816_1 3003394 pncA 
Gene Modulating Resistance CCP45025_1 3003463 kasA 
Gene Modulating Resistance CCP46624_1; 
AAK48268_1 
3003326;3003465 embB 
Gene Modulating Resistance CCP46748_1 3003470 gidB 
Gene Modulating Resistance NP_216424_1 3003392 katG 
Gene Modulating Resistance CAC29514_1 3003298 gyrA 
Gene Modulating Resistance AKJ52802_1 3003310 parC 
rRNA Methyltransferase BAA03674_1 3001300 myrA 
RND Antibiotic Efflux NP_252410_1 3000818 nalC 
RND Antibiotic Efflux NP_252264_1 3000819 nalD 
Class B Beta-Lactamase BAO79439_1 3002362 NDM-12 
General Bacterial Porin AAB57788_1 3000464 por 
Penicillin-binding Protein NP_273462_1 3003937 PBP2 
Gene Modulating Resistance YP_207769_1 3003928 gyrA 
Gene Modulating Resistance YP_208330_1 3003929 parC 
RND Antibiotic Efflux NP_253290_1 3000820;3004059 
;3004060 
nfxB|TypeA NfxB|TypeB NfxB 
Class A Beta-Lactamase CAA79966_1 3003665 NmcR 
MFS Antibiotic Efflux AAS68233_1 3000391 norA 
MFS Antibiotic Efflux CCQ22388_1 3000421 norB 
Gene Modulating Resistance AAF67494_2 3002522 novA 
rRNA Methyltransferase BAF80809_1 3002665 npmA 
Class D Beta-Lactamase CAA33795_1 3003563 NPS 
Class C Beta-Lactamase ABF50909_1 3002521 OCH-8 
Class A Beta-Lactamase CAP12359_2 3002452 OKP-B-19 
ABC-F Ribosomal Protection AAA50325_1 3003036 oleB 
Gene Modulating Resistance AAA26793 3003748 oleC 
Other ARG ABA42119_1 3000865 oleD 
Other ARG ABA42118_2 3000866 oleI 
RND Antibiotic Efflux AAC43969_1 3003037 opcM 
RND Antibiotic Efflux NP_251215_1 3004072 OpmB 
RND Antibiotic Efflux NP_252897_1 3000809 opmD 
RND Antibiotic Efflux BAE06009_1 3003700 opmE 
RND Antibiotic Efflux NP_253661_1 3003682 OpmH 
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RND Antibiotic Efflux BAM10414_1 3003039 oprA 
RND Antibiotic Efflux AAB41958_1 3000802 OprJ 
RND Antibiotic Efflux NP_249118_1 3000379 OprM 
RND Antibiotic Efflux NP_251185_1 3000805 OprN 
RND Antibiotic Efflux YP_001693237_1 3003922 oqxA 
RND Antibiotic Efflux YP_001693238 3003923 oqxB 
Tetracycline Resistance CAA37477_1 3002891 otr(A) 
MFS Antibiotic Efflux AAD04032_1 3002892 otr(B) 
Gene Modulating Resistance AAR96051_1 3002894 otrC 
Class D Beta-Lactamase AIA58911_1 3001396 OXA-1 
Class D Beta-Lactamase ABW70410_1 3001644 OXA-113 
Class D Beta-Lactamase AAN41427_1 3001775 OXA-119 
Class D Beta-Lactamase AAA83417_1 3001407 OXA-12 
Class D Beta-Lactamase AAC46344_1 3001408 OXA-13 
Class D Beta-Lactamase ACI28281_1 3001779 OXA-146 
Class D Beta-Lactamase AAB58555_1 3001413 OXA-18 
Class D Beta-Lactamase AFO09968_1 3001476 OXA-184 
Class D Beta-Lactamase ADZ54048_1 3001766 OXA-192 
Class D Beta-Lactamase ADT70779_1 3001805 OXA-198 
Class D Beta-Lactamase AEM66528_1 3001809 OXA-209 
Class D Beta-Lactamase AEV91550_1 3001710 OXA-211 
Class D Beta-Lactamase AEV91554_1 3001714 OXA-215 
Class D Beta-Lactamase AAD12233_1 3001417 OXA-22 
Class D Beta-Lactamase AFQ90085_1 3001610 OXA-243 
Class D Beta-Lactamase AGC60012_1 3001786 OXA-244 
Class D Beta-Lactamase CCE73593_2 3001503 OXA-258 
Class D Beta-Lactamase AAG35608_1 3001421 OXA-26 
Class D Beta-Lactamase CAC35728_1 3001424 OXA-29 
Class D Beta-Lactamase AAC41449_1 3001398 OXA-3 
Class D Beta-Lactamase AET35493_1 3001777 OXA-347 
Class D Beta-Lactamase AGW83449_1 3001538 OXA-351 
Class D Beta-Lactamase AHA11126_1 3001550 OXA-363 
Class D Beta-Lactamase AAG33665_1 3001431 OXA-37 
Class D Beta-Lactamase AIN56719_1 3002496 OXA-418 
Class D Beta-Lactamase BAP28835_1 3003116 OXA-420 
Class D Beta-Lactamase CAD32565_1 3001770 OXA-43 
Class D Beta-Lactamase CAD58780_1 3001794 OXA-45 
Class D Beta-Lactamase CAA41211_1 3001400 OXA-5 
Class D Beta-Lactamase AAQ76277_1 3001796 OXA-50 
Class D Beta-Lactamase AAR03105_1 3001813 OXA-55 
Class D Beta-Lactamase AAQ08905_1 3001808 OXA-60 
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Class D Beta-Lactamase AAT01092_1 3001773 OXA-61 
Class D Beta-Lactamase AAR32134_1 3001792 OXA-62 
Class D Beta-Lactamase AAP69916_1 3001780 OXA-85 
Class D Beta-Lactamase AAA98406_1 3001404 OXA-9 
Class A Beta-Lactamase AAL78275_1 3002391 OXY-1-3 
Gene Modulating Resistance NP_417544_5 3000024 patA 
Gene Modulating Resistance NP_358969_1 3000025 patB 
Class A Beta-Lactamase YP_001569085_1 3000621 PC1 
Class C Beta-Lactamase ACQ82810_1 3002502 PDC-5 
Class B Beta-Lactamase AJP77059 3003670 PEDO-1 
Class B Beta-Lactamase AJP77071 3003714 PEDO-2 
Class B Beta-Lactamase AJP77076 3003715 PEDO-3 
Class A Beta-Lactamase CAA79968_1 3002363 PER-1 
Other ARG BAG33043_1 3003920 pgpB 
MATE Transporter NP_250052_1 3004077 PmpM 
MFS Antibiotic Efflux NP_358469_1 3000822 pmrA 
Other ARG BAE78116_1 3003576 PmrC 
Other ARG AAC75089_1 3003577 PmrE 
Other ARG AAC75314_1 3003578 PmrF 
Gene Modulating Resistance WP_002530866_1 3003974 gyrA 
Gene Modulating Resistance BAA37152_1 3003702 gyrA|parC 
Other ARG NP_249649_1 3003686 oprD 
Gene Modulating Resistance NP_249870_1 3003895 PhoP 
Gene Modulating Resistance NP_249871_1 3003896 PhoQ 
Gene Modulating Resistance NP_251858_1 3003684 gyrA 
Gene Modulating Resistance NP_253654_1 3003685 parE 
SMR Antibiotic Efflux NP_253677_1 3004038 emrE 
RND Antibiotic Efflux SIP52035_1 3004054 CpxR 
Other ARG AAM15533_1 3003688 PvrR 
MFS Antibiotic Efflux BAJ09383_1 3003046 qacA 
SMR Antibiotic Efflux AAZ42322_1 3003836 qacH 
MFS Antibiotic Efflux AEZ36150_1 3000448 qepA 
Quinolone Resistance ABI50486_1 3002707 QnrA1 
Quinolone Resistance AEL31272_1 3002756 QnrB41 
Quinolone Resistance ACK75961_1 3002787 QnrC 
Quinolone Resistance ACG70184_1 3002788 QnrD1 
Quinolone Resistance AEG74319_1 3002794 QnrS5 
Quinolone Resistance ADI81040_1 3002800 QnrVC3 
Quinolone Resistance AJA36815_1 3003193 QnrVC7 
Class A Beta-Lactamase CAA37699_1 3003565 r39 
Gene Modulating Antibiotic Efflux AFK13828_1 3000823 ramA 
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Other ARG ADV91011_1 3000245 RbpA 
Rifampin Resistance AFO53532_1 3002883 rgt1438 
rRNA Methyltransferase AJD73064_1 3001301 RlmA(II) 
Class B Beta-Lactamase AGU01679_2 3003894 Rm3 
rRNA Methyltransferase BAC20579_1 3000859 rmtA 
rRNA Methyltransferase YP_001816610_1 3000860 rmtB 
rRNA Methyltransferase AIA09786_1 3000861 rmtC 
rRNA Methyltransferase ABY64751_1 3002667 rmtD 
rRNA Methyltransferase AFJ11385_1 3002666 rmtF 
rRNA Methyltransferase AGE00988_1 3002668 rmtG 
rRNA Methyltransferase AGH19769_1 3003198 rmtH 
Class A Beta-Lactamase CAA37052_1 3002995 ROB-1 
RND Antibiotic Efflux AFK13827_1 3000825 robA 
MFS Antibiotic Efflux AAC60781_1 3003048 rosA 
MFS Antibiotic Efflux AAC60780_1 3003049 rosB 
Rifampin Resistance AIA08936_1 3000444 rphA 
Rifampin Resistance APB03222_1 3003992 rphB 
Tetracycline Resistance YP_208874_1 3003930 rpsJ 
ABC-F Ribosomal Protection AGN74946 3003749 salA 
RND Antibiotic Efflux ACH50230_1 3003379 ramR 
Gene Modulating Resistance NP_461214_1 3003926 gyrA 
Gene Modulating Resistance NP_462089_1 3003939 parC 
Gene Modulating Resistance NP_462096_1 3003317 parE 
Other ARG BAD95494_1 3002895 SAT-1 
Other ARG CAA88265_1 3002898 SAT-3 
Other ARG AAB53445_1 3002897 SAT-4 
Gene Modulating Resistance YP_186749_1 3000489 sav1866 
RND Antibiotic Efflux NP_460903_1 3000826 sdiA 
Class A Beta-Lactamase AAK63223_1 3003561 Sed1 
Class B Beta-Lactamase AAT90847_1 3003557 SFB-1 
Class B Beta-Lactamase AAF09244_1 3000849 SFH-1 
rRNA Methyltransferase WP_063978071_1 3000862 sgm 
Class A Beta-Lactamase CAQ03505_1 3001338 SHV-100 
Class B Beta-Lactamase ACT66697_1 3000846 SIM-1 
Class B Beta-Lactamase AAT90846_1 3003556 SLB-1 
Class B Beta-Lactamase BAL14456_1 3000854 SMB-1 
Class A Beta-Lactamase AAG29813_1 3002380 SME-2 
RND Antibiotic Efflux AAD51344_1 3003051 smeA 
RND Antibiotic Efflux AAD51345_1 3003052 smeB 
RND Antibiotic Efflux AAD51346_1 3003053 smeC 
RND Antibiotic Efflux CAC14594_1 3003055 smeD 
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RND Antibiotic Efflux CAC14595_1 3003056 smeE 
RND Antibiotic Efflux CAC14596_1 3003057 smeF 
RND Antibiotic Efflux AAD51348_1 3003066 smeR 
RND Antibiotic Efflux AAD51347_1 3003067 smeS 
Aminoglycoside Nucleotidyltransferase AGW81558_1 3002631 spd 
Class B Beta-Lactamase AJP77080 3003720 SPG-1 
Class B Beta-Lactamase CAD37801_1 3003793 SPM-1 
ABC-F Ribosomal Protection CAA45050_1 3002828 srmB 
Class A Beta-Lactamase BAA23130_1 3002493 SRT-1 
Gene Modulating Resistance ADJ67256 3003319 mprF 
Gene Modulating Resistance WP_001025093 3003323 pgsA 
Gene Modulating Resistance YP_039482_1 3003301 gyrB 
Gene Modulating Resistance YP_039483_1 3003296 gyrA 
Gene Modulating Resistance YP_039996_1 3003285;3003287 rpoB 
Gene Modulating Resistance YP_039997_1 3003291 rpoC 
Gene Modulating Resistance YP_040771_1 3003315 parE 
Gene Modulating Resistance YP_500802_1 3003074 cls 
Gene Modulating Resistance AAK74984_1 3003311 parC 
Gene Modulating Resistance AAL97684_1 3003387 folP 
Penicillin-binding Protein AFC91828_1 3003041 PBP1a 
Penicillin-binding Protein AFC91898_1 3003043 PBP2x 
Penicillin-binding Protein NP_359110_1 3003042 PBP2b 
Gene Modulating Resistance Q8DWT2 3003774 mprF 
Gene Modulating Resistance AAO47226_2 3003318 parY 
Gene Modulating Resistance CAA67349_1 3003359 EF-Tu 
Gene Modulating Resistance AEJ33969_1 3000410 sul1 
Gene Modulating Resistance AAL59753_1 3000412 sul2 
Gene Modulating Resistance ACJ63260_1 3000413 sul3 
Gene Modulating Resistance APB03219_1 3003986 TaeA 
MFS Antibiotic Efflux CAA03986_1 3000343 tap 
MFS Antibiotic Efflux AAA67509_1 3003554 tcmA 
MFS Antibiotic Efflux BAA07390_1 3002893 tcr3 
Class A Beta-Lactamase AHA80960_1 3001388 TEM-211 
MFS Antibiotic Efflux AAD09860_1 3000561 tet(30) 
MFS Antibiotic Efflux CAC80727_1 3000476 tet(31) 
MFS Antibiotic Efflux CAD12227_1 3000478 tet(33) 
Gene Modulating Resistance AAK37619_1 3000481 tet(35) 
MFS Antibiotic Efflux AAV80464_1 3000565 tet(38) 
MFS Antibiotic Efflux AAW66497_1 3000566 tet(39) 
MFS Antibiotic Efflux AFK31666_1 3000567 tet(40) 
MFS Antibiotic Efflux AAP93922_1 3000569 tet(41) 
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MFS Antibiotic Efflux ACD35503_1 3000572 tet(42) 
MFS Antibiotic Efflux ACS83748_1 3000573 tet(43) 
MFS Antibiotic Efflux ADE08374_2 3003196 tet(45) 
MFS Antibiotic Efflux YP_007503840_1 3000165 tet(A) 
MFS Antibiotic Efflux AAO16462_1 3000167 tet(C) 
MFS Antibiotic Efflux CAE51745_1 3000168 tet(D) 
MFS Antibiotic Efflux AAA71915_1 3000173 tet(E) 
MFS Antibiotic Efflux AAD25538_1 3000174 tet(G) 
MFS Antibiotic Efflux CAA75663_1 3000175 tet(H) 
MFS Antibiotic Efflux AAD12753_1 3000177 tet(J) 
MFS Antibiotic Efflux YP_003283625_1 3000178 tet(K) 
MFS Antibiotic Efflux AAA22851_1 3000179 tet(L) 
MFS Antibiotic Efflux AAB84282_1 3000181 tet(V) 
MFS Antibiotic Efflux AAC72341_1 3000182 tet(Y) 
MFS Antibiotic Efflux AAD25063_1 3000183 tet(Z) 
Tetracycline Resistance CAC41371_1 3000196 tet32 
Tetracycline Resistance BAB59035_1 3002870 tet34 
Tetracycline Resistance CAD55718_1 3000197 tet36 
Tetracycline Resistance AAN28721_1 3002871 tet37 
Tetracycline Resistance CBH51823_1 3000556 tet44 
Gene Modulating Resistance AET10444_1 3004032 tetA(46) 
MFS Antibiotic Efflux APB03214_1 3003980 tetA(48) 
Gene Modulating Resistance ANZ79240_1 3004035 tetA(60) 
MFS Antibiotic Efflux AAA20116_1 3000180 tetA(P) 
Gene Modulating Resistance AET10445_1 3004033 tetB(46) 
MFS Antibiotic Efflux APB03215_1 3003981 tetB(48) 
Gene Modulating Resistance ANZ79241_1 3004036 tetB(60) 
Tetracycline Resistance AAA20117_1 3000195 tetB(P) 
Tetracycline Resistance CAJ67339_1 3000186 tetM 
Tetracycline Resistance AAA23033_1 3000190 tetO 
Tetracycline Resistance CAA79727_1 3000191 tetQ 
MFS Antibiotic Efflux CAD09823_1 3003479 tetR 
Tetracycline Resistance AAA25293_1 3000192 tetS 
Tetracycline Resistance AAF01499_1 3000193 tetT 
Tetracycline Resistance ACA23185_1 3000194 tetW 
Tetracycline Resistance AAA27471_1 3000205 tetX 
Class B Beta-Lactamase CAC33832_1 3000851 THIN-B 
Class A Beta-Lactamase AAD37403_1 3003202 TLA-1 
Class A Beta-Lactamase CAG27800_1 3003203 TLA-2 
Class A Beta-Lactamase AAA19882_1 3003562 TLE 
rRNA Methyltransferase AAD12162_1 3001299 tlrB 
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ABC-F Ribosomal Protection AAA26832_1 3002827 tlrC 
Other ARG CAB12108_2 3003059 tmrB 
Gene Modulating Resistance ACN32294_1 3000237 tolC 
RND Antibiotic Efflux NP_248846_1 3003679 TriA 
RND Antibiotic Efflux NP_248847_1 3003680 TriB 
RND Antibiotic Efflux NP_248848_1 3003681 TriC 
rRNA Methyltransferase CCP44409_1 3003060 tsnr 
Class B Beta-Lactamase AAN63648_1 3000844 TUS-1 
Gene Modulating Resistance WP_004025678_1 3003305 gyrB 
Gene Modulating Resistance WP_010891786_1 3003309 parC 
Glycopeptide Resistance AAA65956_1 3000010 vanA 
Glycopeptide Resistance AHH83938_1 3000013 vanB 
Glycopeptide Resistance AAA24786_1 3000368 vanC 
Glycopeptide Resistance AAM09849_1 3000005 vanD 
Glycopeptide Resistance AAL27442_1 3002907 vanE 
Glycopeptide Resistance AAF36803_1 3002908 vanF 
Glycopeptide Resistance ABA71731_1 3002909 vanG 
Glycopeptide Resistance AAA65955_1 3002942 vanHA 
Glycopeptide Resistance AAB05626_1 3002943 vanHB 
Glycopeptide Resistance AAM09850_1 3002944 vanHD 
Glycopeptide Resistance AAF36802_1 3002945 vanHF 
Glycopeptide Resistance ACL82960_1 3002947 vanHM 
Glycopeptide Resistance AHA41499_1 3002948 vanHO 
Glycopeptide Resistance AEP96393_1 3003723 vanI 
Glycopeptide Resistance NP_627787 3002914 vanJ 
Glycopeptide Resistance WP_011461306 3003727 vanKI 
Glycopeptide Resistance ABX54687_1 3002910 vanL 
Glycopeptide Resistance ACL82961_1 3002911 vanM 
Glycopeptide Resistance AEP40500_1 3002912 vanN 
Glycopeptide Resistance AHA41500_1 3002913 vanO 
Glycopeptide Resistance AAA65953_1 3002919 vanRA 
Glycopeptide Resistance AAB05622_1 3002921 vanRB 
Glycopeptide Resistance AAF86641_1 3002922 vanRC 
Glycopeptide Resistance AAM09851_1 3002923 vanRD 
Glycopeptide Resistance AAL27445_1 3002924 vanRE 
Glycopeptide Resistance AAR84672_1 3002925 vanRF 
Glycopeptide Resistance ABA71727_1 3002926 vanRG 
Glycopeptide Resistance WP_011461303 3003728 vanRI 
Glycopeptide Resistance ABX54691_1 3002927 vanRL 
Glycopeptide Resistance ACL82957_1 3002928 vanRM 
Glycopeptide Resistance AEP40503_1 3002929 vanRN 
 
  115 
Glycopeptide Resistance AHA41505_1 3002930 vanRO 
Glycopeptide Resistance AAA65954_1 3002931 vanSA 
Glycopeptide Resistance AAB05623_1 3002932 vanSB 
Glycopeptide Resistance AAF86642_1 3002933 vanSC 
Glycopeptide Resistance ACM47284 3002934 vanSD 
Glycopeptide Resistance AAL27446_1 3002935 vanSE 
Glycopeptide Resistance AAR84673_1 3002936 vanSF 
Glycopeptide Resistance ABA71728_1 3002937 vanSG 
Glycopeptide Resistance WP_011461302_1 3003726 vanSI 
Glycopeptide Resistance ABX54692_1 3002938 vanSL 
Glycopeptide Resistance ACL82958_1 3002939 vanSM 
Glycopeptide Resistance AEP40504_1 3002940 vanSN 
Glycopeptide Resistance AHA41504_1 3002941 vanSO 
Glycopeptide Resistance AAD22403_1 3002970 vanTC 
Glycopeptide Resistance AAL27444_1 3002971 vanTE 
Glycopeptide Resistance ABA71733_1 3002972 vanTG 
Glycopeptide Resistance ABX54689_1 3002973 vanTmL 
Glycopeptide Resistance AEP40502_2 3002975 vanTN 
Glycopeptide Resistance ABX54690_1 3002974 vanTrL 
Glycopeptide Resistance ABA71726_1 3000575 vanU 
Glycopeptide Resistance AAO82019_1 3002916 vanV 
Glycopeptide Resistance AAB05625_1 3002964 vanWB 
Glycopeptide Resistance ABA71730_1 3002965 vanWG 
Glycopeptide Resistance WP_005813024_1 3003724 vanWI 
Glycopeptide Resistance AAA65957_1 3002949 vanXA 
Glycopeptide Resistance AAB05628_1 3002950 vanXB 
Glycopeptide Resistance AAM09852_1 3003070 vanXD 
Glycopeptide Resistance AAF36804_1 3002952 vanXF 
Glycopeptide Resistance WP_015943580_1 3003725 vanXI 
Glycopeptide Resistance ACL82962_1 3002953 vanXM 
Glycopeptide Resistance AHA41501_1 3002954 vanXO 
Glycopeptide Resistance AAF61331_1 3002966 vanXYC 
Glycopeptide Resistance AAL27443_1 3002967 vanXYE 
Glycopeptide Resistance ABA71732_1 3003069 vanXYG 
Glycopeptide Resistance ABX54688_1 3002968 vanXYL 
Glycopeptide Resistance AEP40501_1 3002969 vanXYN 
Glycopeptide Resistance AAA65958_1 3002955 vanYA 
Glycopeptide Resistance AAB05624_1 3002956 vanYB 
Glycopeptide Resistance AAM09853_1 3002957 vanYD 
Glycopeptide Resistance AAF36805_1 3002958 vanYF 
Glycopeptide Resistance ABA71729_1 3002959 vanYG1 
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Glycopeptide Resistance ACL82959_1 3002961 vanYM 
Glycopeptide Resistance AAA65959_1 3002962 vanZA 
Glycopeptide Resistance AAF36806_1 3002963 vanZF 
Other ARG AAA26683_1 3002840 vatA 
Other ARG AAA86871_1 3002841 vatB 
Other ARG AAC61671_1 3002842 vatC 
Other ARG AAK84316_1 3002843 vatD 
Other ARG AAF86220_1 3002844 vatE 
Other ARG AAF63432 3003744 vatF 
Other ARG ACX92987_1 3002845 vatH 
Other ARG APB03220_1 3003987 VatI 
Class A Beta-Lactamase ALU64000 3003713 VCC-1 
Class A Beta-Lactamase AAK14293_1 3002378;3003711 VEB-9|VEB-1a 
ABC-F Ribosomal Protection AGN33258_1 3002829 vgaA 
ABC-F Ribosomal Protection AAB95639_1 3000118 vgaB 
ABC-F Ribosomal Protection AMP35312_1 3002831 vgaC 
ABC-F Ribosomal Protection ACX92986_2 3002832 vgaD 
ABC-F Ribosomal Protection CBY88983_1 3002833 vgaE 
Other ARG AAA98349_1 3001307 VgbA 
Other ARG AAC61670_1 3001308 VgbB 
Other ARG APB03225_1 3003990 VgbC 
Class B Beta-Lactamase AAN52134_1 3002275 VIM-5 
Class B Beta-Lactamase CAD61201_1 3002277 VIM-7 
Other ARG CAA26235_1 3003061 vph 
Class A Beta-Lactamase AAX55643_1 3003558 y56 
SMR Antibiotic Efflux CAB13166_1 3003063 ykkC 
SMR Antibiotic Efflux CAB13167_1 3003064 ykkD 
Gene Modulating Resistance NP_416715_1 3003952 YojI 
 
